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ABSTRACT  
JIAN HU: Cell Cycle and Cell Growth Regulation by the 
 CUL4-DDB1-ROC1 Ubiquitin Ligases 
(Under the direction of Dr. Yue Xiong) 
 
 Timely and efficient destruction of proteins in the cell is critical for its normal function.  
The ubiquitin-proteasome system is the major pathway by which the cell targets proteins for 
degradation in a specific manner.  Ubiquitination is a process in which ubiquitin is 
covalently conjugated to proteins via an enzymatic cascade composed of an E1 activating 
enzyme, an E2 conjugating enzyme and an E3 ubiquitin ligase.  The cullins are a family of 
evolutionarily conserved proteins that assemble a large family of cullin-dependent E3 ligases 
(CDLs).   A unique feature of CDLs is that the cullins, through a conserved N-terminal 
domain interact with a specificity factor - either directly or through an adaptor - to recruit 
specific substrates.  This dissertation is directed toward understanding the mechanism by 
which CUL4 targets substrates.  I show here that CUL4 utilizes an adaptor DDB1 
(damaged DNA binding protein 1) and the specificity factor DWD (DDB1 binding and 
WD40 repeat) proteins to target various substrates.  Specifically, a DNA pre-replicative 
licensing factor CDT1 is ubiquitinated and degraded by CUL4-DDB1-CDT2 ubiquitin ligase 
in response to DNA damage, thereby constituting a novel cell cycle G1-S checkpoint.  
Although the mechanistic role is not known, PCNA (proliferating cell nuclear antigen) is 
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required for the ubiquitination of CDT1 catalyzed by CUL4-DDB1-CDT2.  TSC2 
(Tuberous Sclerosis complex) is an important tumor suppressor which plays an essential role 
inhibiting cell growth.  The majority of disease-associated mutations targeting TSC2 results 
in a substantial decrease in protein level, suggesting that protein turnover plays a critical role 
in TSC regulation.  In this study, I present the evidence indicating that CUL4-DDB1-FBW5 
is an E3 ubiquitin ligase regulating TSC2 protein stability.   
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INTRODUCTION 
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Ubiquitin-mediated proteolysis 
   Timely and efficient destruction of proteins in the cell is critical for its normal function.  
The ubiquitin-proteasome system is the major pathway by which the cell targets proteins for 
degradation in a specific manner.  That the modification of ubiquitin serves a proteolytic 
signal was first discovered in rabbit reticulocyte lysates while studying the degradation of 
misfolded proteins (Hershko and Ciechanover, 1982).  Ubiquitin is an abundant, 76 amino 
acid protein highly conserved between species, differing only three amino acids between 
yeast and mammals (Ozkaynak et al., 1984).  Ubiquitin gene usually contains several 
identical coding repeats and transcribes a precursor containing several ubiquitin repeats. 
Ubiquitin only becomes mature after the cleavage of the first 5 amino acids following a 
Glycine-Glycine dipeptide repeat (amino acid 75 and 76) at the C-terminal of the ubiquitin 
repeat (Ozkaynak et al., 1984).  Deubiquitinating enzymes or ubiquitin proteases (UBP) are 
required for the maturation of ubiquitin as well as the regeneration of ubiquitin pool from 
conjugated ubiquitin chains (Jonnalagadda et al., 1989).  Ubiquitination is a process in 
which ubiquitin is covalently conjugated to proteins via an enzymatic cascade composed of 
an E1 activating enzyme, an E2 conjugating enzyme and an E3 ubiquitin ligase.  There are 
several critical residues within the ubiquitin protein that are required for its tagging activity.  
The C-terminal Glycine is the site which is covalently conjugated on substrates or another 
ubiquitin.  Ubiquitin contains seven lysine residues (K6, K11, K27, K29, K33, K48 and 
K63) which can be conjugated by the C-terminal Glycine residue from another ubiquitin to 
form diverse types of chain linkage.  Ubiquitin chains linked through K48-Glycine and 
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K63-Glycine are the best characterized, which signal proteasome-mediated degradation and 
non-proteolytical functions, respectively (Chen et al., 2006; Hofmann and Pickart, 1999; 
Mastrandrea et al., 1999; Pickart and Raasi, 2005; Raasi and Pickart, 2005; Raasi et al., 
2005).    
     
    Ubiquitination requires a cascade of three enzymatic reactions.  This series of 
reactions begins with activation of ubiquitin by an ubiquitin activating enzyme, or E1, in an 
ATP dependent manner.  The C-terminal glycine of ubiquitin is covalently linked to an 
internal Cysteine residue within the E1 through a thiol ester bond, utilizing the energy 
released from hydrolysis of ATP to AMP and PPi (Ciechanover et al., 1982; Pickart and 
Vella, 1988).   The charged ubiquitin is then transferred to an ubiquitin conjugating 
enzyme (Ubc), or E2, forming another thiol ester bond (Haas and Bright, 1988; Pickart and 
Rose, 1985).  From here, the ubiquitin can be transferred to an ε-amino group of a lysine or 
the α-amino group of substrates directly, or indirectly through the facilitation by an E3 
ubiquitin ligase (Hershko, 1991; King et al., 1996).  Subsequent ubiquitin can be ligated to 
a lysine residue (K48 in most cases) within the previous ubiquitin repeatedly.  The series of 
ligation of ubiquitin results in a polyubiquitin chain.  The polyubiquitinated substrates can 
be rapidly detected and degraded by 26S proteasome (Figure 1.1).  
 
     The ubiquitin enzymatic system is in a hierarchical structure: there is only one E1 and 
several E2s in all species.  Hundreds of E3s have been identified and the number is still 
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increasing.  E4 has been discovered recently and it is proposed to be involved in ubiquitin 
chain elongation.  However, its activity appears only be restricted in a limited number of 
substrates (Koegl et al., 1999).        
 
During the past two decades, numerous studies have unraveled the role of 
ubiquitin-mediated proteolysis in an extremely broad array of cellular processes, among 
which are cell cycle, cell division, cell growth, DNA repair, differentiation, development, the 
cellular response to extracellular effectors and stress, modulation of cell surface receptors 
and ion channels, regulation of immune and inflammatory responses and biogenesis of 
organelles (Ciechanover et al., 2000a).  Considering these numerous processes regulated by 
ubiquitin-mediated proteolysis, it is not surprising that the malfunction of this system has 
been implicated in pathogenesis of many diseases, such as cancer, neurodegenerative disease, 
immune disease, Cystic Fibrosis, Angelman's syndrome and Liddle's syndrome 
(Ciechanover et al., 2000b).  
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Figure 1.1 The ubiquitin-mediated proteolysis pathway.  
Ubiquitin is a 76 amino acid protein which is highly conserved between species.  The 
ubiquitination requires an enzymatic cascade composed of an ubiquitin activating enzyme 
E1, an ubiquitin conjugating enzyme E2 and an ubiquitin ligase E3. Activation of ubiquitin 
by E1 requires the energy provided by ATP hydrolysis, resulting in a high energy thiol ester 
linkage, indicated by a letter “S”. Subsequent degradation of polyubiquitinated proteins is 
processed by the 26S proteasome in an ATP dependent manner. The ubiquitin-mediated 
proteolysis pathway has been reported to regulate numerous cellular processes.  
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The Cullin gene family   
   E3 ligases can be divided into two major families.  The HECT family of E3s contains a 
domain homologous to the E6-associated protein (E6AP) carboxyl terminus that can form 
thiol ester linkage with ubiquitin.  Multiple cellular proteins with diverse structures contain 
the HECT domain (five in budding yeast and around 30 in humans), implicating many 
substrates and physiological functions for the HECT family of E3 ligases (Pickart, 2001).  
The RING family of E3s contains either an intrinsic RING finger domain or an associated 
RING subunit essential for the ubiquitin ligase activity.  RING finger domain was initially 
identified by a database search using an N-terminal sequence of a protein called RING1 
(Really Interesting New Gene 1), and then refined by a sequence pattern matching program 
PROMOT(Sternberg, 1991).  The RING finger sequence is defined as 
Cys-X2-Cys-X9-39-Cys-X1-3-His-X2-3-Cys-X2-Cys-X4-48-Cys-X2-Cys, in which X is any 
amino acid.  The RING finger domain contains eight potential metal ligands (seven Cystein 
residues and one Histidine residue) and binds to two zinc atoms tetrahedrally by either four 
Cysteins or three Cysteins and one Histidine.  In this system, the first pair of ligands share a  
zinc (Cys 1 and Cys 2) atom with the third pair (Cys 4 and Cys 5), whereas the second pair 
(Cys 3 and His 1) share the other zinc atom with the fourth pair (Cys 6 and Cys 7) (Figure 
1.2)  
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Figure 1.2 Cross-braced structure of RING finger domain.  
   Eight Cysteins and Histidines within RING finger domain bind to two zinc atoms 
tetrahedrally, forming a cross-braced structure. Adapted from Borden & Freemont, Curr 
Opin Struc Biol 6:395-401, 1996 
 
   E3 ubiquitin ligases contain two distinct activities: catalysis of isopeptide bond 
formation and recruitment of substrates to this catalytic activity (Hershko and Ciechanover, 
1998).  The cullins are a family of evolutionarily conserved proteins that assemble a large 
family of cullin-dependent E3 ligases (CDL).  The human cullin family includes six closely 
related proteins (CUL1, CUL2, CUL3, CUL4A, CUL4B and CUL5) and three distantly 
related proteins (CUL7, PARC and APC2).  All cullins contain a conserved 
carboxy-terminal domain of approximately 100 amino acids, which binds to a small RING 
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finger protein: ROC1 (RING of Cullins, also known as Hrt1 and Rbx1), ROC2 or APC11 
(Deshaies, 1999; Jackson et al., 2000).   ROC proteins activate an E2 
ubiquitin-conjugating enzyme to catalyze polyubiquitination through their RING finger, and 
bind with cullins through an N-terminal sequence flanking the RING domain to recruit the 
catalytic function of the E2 to cullins (Furukawa et al., 2000).  A unique feature of CDLs is 
that the cullins, through a conserved N-terminal domain, interact with a specificity factor  
(substrate targeting protein)— either directly or through an adaptor protein or adaptor 
complex — to recruit specific substrates, rather than binding to substrates directly as most 
other ligases do.  The SKP1 adaptor bridges an F-box protein to CUL1-dependent ligases 
(Bai et al., 1996; Feldman et al., 1997; Skowyra et al., 1997; Zheng et al., 2002a), a 
heterodimeric elongins B and C complex brings VHL (von Hippel-Lindau) box proteins and 
SOCS (suppressor of cytokine signaling) box proteins to CUL2-dependent and 
CUL5-dependent ligases, respectively (Kamura et al., 2001; Kamura et al., 2004; Kamura et 
al., 1998; Stebbins et al., 1999; Zhang et al., 1999), whereas CUL3 binds directly to the BTB 
domain (Broad-Complex C (BR-C), Tramtrack (Ttk) and Bric-a-brac) (Furukawa et al., 2003; 
Geyer et al., 2003; Pintard et al., 2003; Xu et al., 2003).  The presence of numerous 
substrate specificity factors — mammals express more than 60 F-box, 40 SOCS and 200 
BTB proteins — suggests that individual cullins may assemble into multiple E3 ligase 
complexes. (Figure 1.3 and Figure 1.4) 
The assembly of these multi-subunit cullin-dependent ubiquitin ligase complexes, and 
thus the ubiquitination of substrates, is tightly regulated: all cullins are negatively regulated 
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by CAND1 (cullin-associated and neddylation-dissociated 1), a 120 kDa protein that 
consists of 27 tandem HEAT (huntingtin-elongation-A subunit-TOR) repeats and prevents 
binding of the adaptor protein and substrates to the complex. To assemble active 
ligase-substrate complexes, cullins are covalently modified by a small ubiquitin-like 
modifier, Nedd8, to dissociate CAND1 (Goldenberg et al., 2004; Liu et al., 2002; Zheng et 
al., 2002a).  Dissociation of CAND1 from cullins exposes the site required for the binding 
with adaptors and hence recruits substrates. To inactive cullins, the COP9 signalosome 
removes the conjugated Nedd8, allowing CAND1 re-associates with cullins and resumes the 
inhibition (Lyapina et al., 2001).   This seemingly complex regulation is essential to ensure 
the assembly of individual cullin-ROC cores, which are likely present in the cell as 
rate-limiting factor, into multiple distinct substrate-cullin-ROC complexes. 
    
DNA replication initiation is tightly regulated 
 
   DNA replication in eukaryotic cells starts from the concerted formation of a multiprotein 
complex called the pre-replicative complex (pre-RC) in late M and early G1 phases of the 
cell cycle.  The assembly of pre-RC begins with the loading of a six-component complex 
ORC (origin recognition complex) which binds to replication origins (Gilbert, 2001).  The 
loading of ORC in metazoan appears to be less strict than single cell organisms, which might 
explain the broad initiation zones of many metazoan replication origins (Machida et al., 
2005).  ORC on the chromatin recruits two replication licensing factors, Cdc6 and CDT1, 
both of which are required to the loading of a replicative helicase MCM2-7 (Figure 1.5). 
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Figure 1.3 Substrate-targeting mechanisms of cullin family of E3 ligases.  
 
   CUL1 utilizes SKP1-F box proteins, CUL2 utilizes Elongin B/C-VHL box proteins, 
CUL5 utilizes Elongin B/C-SOCS box proteins, and CUL3 utilize BTB proteins to target 
various substrates. The substrate-targeting mechanism of CUL4 was solved by my 
colleagues and me, which will be presented in the thesis.   
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Figure 1.4 The structure of SCFSKP2. 
 
   The crystal structure of SCFSKP2 highlights the extended modular nature of cullin–RING 
ligases (Protein Data Bank file 1LDK). The F-box portion and the substrate-binding region 
of the substrate receptor SKP2 are shown — the former binds to the adaptor protein SKP1 
and the latter extends towards the ubiquitin-conjugating enzyme (E2), which is bound to the 
E2-docking site on the RING protein. The substrate-specificity module of SCF is separated 
from the E2-docking site by a series of three cullin repeats that form the curved N-terminal 
stalk of cullin-1 (CUL1). The distance between a bound substrate and the active-site cysteine 
of an E2 that is docked on the RING protein has been estimated by computational methods 
to be 50 Å. Yellow spheres represent zinc molecules, and the NEDD8 attachment site is 
highlighted. SCF, SKP1, CUL1, F-box protein. From Petroski, M.D., and Deshaies, R.J. 
Nature reviews 6, 9-20, 2005 
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Cdc6 belongs to the AAA+ family of ATPase (Harvey and Newport, 2003), while CDT1 
does not have any defined motif or domain.  The replicative helicase is a ring-shaped 
hexamer composed of Mcm2 to Mcm7.  Mcm2 to Mcm7 are structurally related proteins 
containing AAA+ ATPase domain, which is required for unwinding the DNA double helix of 
the replication origin (Pacek and Walter, 2004).  Pre-RC is activated by CDKs (cyclin 
dependent kinases), DDKs (Dbf4 dependent kinases) and the assembly of a second set of 
factors including Mcm10, GINS, Sld2, Cdc45, Sld3, Dbp11, RPA and replicative 
polymerases upon the entry of S phase (Araki et al., 1995; Brown and Kelly, 1999; Lee et al., 
2003; Masumoto et al., 2002; Takayama et al., 2003; Takeda and Dutta, 2005; Wang and 
Elledge, 1999; Wohlschlegel et al., 2002).   
    Maintaining genome integrity requires precise regulation of DNA replication to ensure 
that the genome is replicated once and only once per cell cycle.  The key mechanism is to 
inactive the pre-RC once DNA replication initiated. There are three mechanisms reported to 
inhibit pre-RC formation after the onset of S phase: (1) inhibition of pre-RC by binding 
between CDT1 and geminin, (2) degradation of CDT1 by ubiquitin-mediated proteolysis, 
and (3) phosphorylation of pre-RC components by Cdk in G2 phase (Figure 1.6).  Geminin 
is conserved from the worm Caenorhabditis elegans to human, but has not been found in 
yeast.  Geminin is present in S, M and G2 phases, but absent in G1 phase.  At the 
metaphase-to-anaphase transition, geminin is ubiquitinated by APC and degraded by the 26S 
proteasome to allow the formation of pre-RC (McGarry and Kirschner, 1998). 
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Figure 1.5 Assembly of pre-replicative complex. 
  
    Pre-RC is loaded onto chromatin in a concerted order which begins with loading or 
ORC. ORC recruits Cdc6 and CDT1, which are both required for the loading of the 
replicative helicase Mcm2-7. Pre-RC formation occurs in late M and early G1 phases of the 
cell cycle and activated upon the entry of S phase. Adapted from Takeda, D.Y., and Dutta, A. 
Oncogene 24, 2827-2843, 2005. 
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Geminin prevents the formation of pre-RC by binding to CDT1 and inhibiting Mcm2-7 
loading (Wohlschlegel et al., 2000).  Opposite to geminin, CDT1 accumulates in late M and 
G1 phases, but is absent in S and G2 phases. The degradation of CDT1 by 
ubiquitin-proteasome pathway in S and G2 phases has been reported in C. elegans and 
human (Higa et al., 2003; Li et al., 2003; Liu et al., 2004; Nishitani et al., 2004; Zhong et al., 
2003).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Three possible mechanisms for the inhibition of the second-round pre-RC 
formation 
   Rereplication is prevented by inhibition of pre-RC formation by three mechanisms: (A) 
An inhibitory complex between geminin and CDT1; (B) CDT1 degradation in S phase by an 
ubiquitin-mediated proteolysis; (C) High activity of cyclin dependent kinase (Cdk) in G2 
and M phases inactivates (or destabilizes) pre-RC components Cdc6, CDT1, MCM2-7, and/ 
or ORC. From Machida, Y.J., Hamlin, J.L., and Dutta, A. Cell 123, 13-24, 2005. 
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TSC-mTOR pathway has a central role in regulation of cell growth 
   The Tor (target of rapamycin) genes were first identified in yeast as the targets of the 
drug rapamycin (Heitman et al., 1991), and the mammalian counterpart mTOR was 
discovered later (Brown et al., 1994; Chiu et al., 1994; Sabatini et al., 1994).  TOR belongs 
to the phosphoinositide kinase-related kinase family, but it phosphrylate proteins instead of 
phosphoinositides (Harris and Lawrence, 2003).  Genetic and biochemical studies in the 
past decade have shown that TOR plays a central role in controlling cell growth, 
proliferation and metabolism, and regulates numerous cellular processes, including 
translation, transcription, mRNA turnover, protein stability, actin cytoskeletal organization 
and autophagy (Inoki et al., 2005; Jacinto and Hall, 2003).  Ribosomal S6 kinase (S6K) and 
eukaryotic initiation factor 4E binding protein 1 (4EBP1), two essential regulators of protein 
translation, are best-characterized substrates of mTOR (Harris and Lawrence, 2003) (Figure 
1.7).  S6K is the major kinase for the ribosomal protein S6, phosphorylation of which 
selectively increases the translation of mRNAs containing a tract of pyrimidines motif.  
These mRNAs usually translate ribosomal proteins and other translation regulators, through 
which S6K enhances overall protein synthesis of the cell (Avruch et al., 2001; Meyuhas, 
2000).  4EBP1, another target of mTOR, plays a role as a translation inhibitor by binding 
eukaryotic initiation factor 4E (eIF4E), which recognizes the 5’ end cap of eukaryotic 
mRNAs (Gingras et al., 1999).   Phosphorylation of 4EBP1 by mTOR dissociates the 
interaction between eIF4E and 4EBP1, thereby relieving the inhibition of 4EBP1 on eIF4E 
(Gingras et al., 1999).  eIF4E increases the translation of a subset of growth stimulating 
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factors, including Cylin D1, c-Myc and vascular endothelial growth factor (VEGF) 
(Mamane et al., 2004).   
     mTOR links the cell growth to multiple extracellular and intracellular signals, 
including growth factors, nutrients and energy (Harris and Lawrence, 2003; Inoki et al., 
2003b; Jacinto and Hall, 2003).  All these signals act on mTOR through the tuberous 
sclerosis complex (TSC) gene products TSC1 and TSC2 and a small G protein Rheb (Figure 
1.7).  Tuberous sclerosis is an autosomal dominant disease causes benign tumors 
(hamartomas) in a variety of organs with an incidence estimated to be 1 in 6000 live births.  
TSC1(also known as hamartin) and TSC2 (also known as tuberin) are two genes whose 
mutations are believed to cause this disease (Young and Povey, 1998).   TSC2 gene 
encodes a 200 kDa protein containing a coiled-coil domain and a GAP (GTPase activating 
protein) domain, which inhibits the small G protein Rheb, an activator of mTOR (Inoki et al., 
2003a).  PI3K (phosphoinositide kinase-3) is a prosurvival and pro-oncogenic protein 
which is activated by growth factors such as insulin(Cantley, 2002). Activated PI3K 
phosphorylates di-phosphorylated phosphoinositide (PtdInsP2) on the third carbon of the 
inositol ring, resulting in tri-phosphorylated phosphoinositide (PtdInsP3) which activates 
Akt (also known as PKB), another pro-oncogenic protein (Brunet et al., 1999; Cantley, 
2002).  Biochemical studies in both D. melanogaster and mammalian cells showed that Akt 
phosphorylates TSC2 and inhibits its function (Inoki et al., 2002; Manning et al., 2002; 
Potter et al., 2002).  
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Figure 1.7 TSC-mTOR pathway in the regulation of translation.  
   
   mTOR plays a centrol role in the regulation of protein synthesis.  TSC1/2 are the major 
inhibitors of mTOR function.  TSC-mTOR pathway is regulated by different signals, 
including growth factors, nutrients and ATP depletion.  X represents unknown factors. IRS: 
insulin receptor substrate. Adapted from Inoki, K., Corradetti, M.N., and Guan, K.L. Nat 
Genet 37, 19-24, 2005.  
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    PTEN, a potent tumor-suppressor, acts as a 3’ phosphotase to decrease the PtdInsP3 
level, thereby relieving the inhibition on TSC2 (Kaper et al., 2006).  The essential role of 
PTEN in regulation of TSC2-mTOR pathway has been highlighted by the discoveries that 
PTEN mutation causes several hamartoma syndromes, including Cowden disease, 
Bannayan-Riley-Ruvalcaba syndrome (BRRS), Lhermitte-Duclos disease and Proteus 
syndrome (Eng, 2003; Inoki et al., 2005).  In response to low intracellular ATP/AMP ratio, 
the 5’ AMP-activating protein kinase (AMPK) phosphorylates and activates TSC2, thereby 
inhibiting mTOR function (Hardie et al., 1998; Hawley et al., 2003; Inoki et al., 2003b).  
Notably, LKB1 (also known as STK11), an upstream of AMPK, has been shown inactivated 
in an hamartoma syndrome: Peutz-Jegher syndromes (Hawley et al., 2003; Hong et al., 
2003).   
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Summary 
This dissertation describes the work I have taken to explore the mechanism by which 
CUL4 targets substrates and the regulation of DNA replication, cell cycle and cell growth by 
CUL4-DDB1-ROC1 ubiquitin ligase.   
      Chapter II presents the paper “Targeted ubiquitination of CDT1 by the 
DDB1-CUL4A-ROC1 ligase in response to DNA damage” (Hu et al., 2004), in which I am the 
first author. 
Chapter III presents the paper “An evolutionarily conserved function of proliferating 
cell nuclear antigen for CDT1 degradation by the Cul4-Ddb1 ubiquitin ligase in response to 
DNA damage” (Hu and Xiong, 2006), in which I am the first author. 
 
Chapter IV describes my investigation on the role of CUL4-DDB1-FBW5-ROC1 
ubiquitin ligase in degrading TSC2. 
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Chapter II 
CUL4-DDB1-CDT2-ROC1 TARGET CDT1 FOR DEGRADATION IN 
RESPONSE TO DNA DAMAGE  
 
(Including modified portions of “ CUL4-DDB1-ROC1 TARGET CDT1 FOR 
DEGRADATION IN RESPONSE TO DNA DAMAGE,” Jian Hu, Chad McCall, Tomohiko 
Ohta, and Yue Xiong, Nat Cell Biol, 2004 Oct;6(10):1003-9) 
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Summary 
   Cullins assemble a potentially large number of ubiquitin ligases by binding to the RING 
protein ROC1 to catalyze polyubiquitination, as well as binding to various specificity factors 
to recruit substrates.  The CUL4A gene is amplified in human breast and liver cancers, and 
loss-of-function of Cul4 results in the accumulation of the replication licensing factor CDT1 
in Caenorhabditis elegans embryos and ultraviolet (UV)-irradiated human cells.  Here, I 
present that human UV-damaged DNA-binding protein DDB1 associates stoichiometrically 
with CUL4A in vivo, and binds to an amino-terminal region in CUL4A in a manner 
analogous to SKP1, VHL, SOCS and BTB binding to CUL1, CUL2, CUL5 and CUL3, 
respectively.  As with SKP1−CUL1, the DDB1−CUL4A association is negatively regulated 
by the cullin-associated and neddylation-dissociated protein, CAND1.  DDB1 and CDT1 
associate with each other, and ectopically expressed DDB1 bridges CDT1 to CUL4A.  I 
also describe that a DWD (DDB1-binding WD40) box protein CDT2 recruits CDT1 to 
CUL4-DDB1. Silencing DDB1 or CDT2 prevented UV-induced rapid CDT1 degradation in 
vivo and CUL4A-mediated CDT1 ubiquitination in vitro.   I suggest that DDB1 and CDT2 
targets CDT1 for ubiquitination by a CUL4A-dependent ubiquitin ligase, CDL4ADDB1-CDT2, 
in response to UV irradiation. 
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Background    
E3 ubiquitin ligases contain two distinct activities: catalysis of isopeptide bond 
formation and recruitment of substrates to this catalytic activity (Hershko and Ciechanover, 
1998).  The cullins are a family of evolutionarily conserved proteins that assemble a large 
family of cullin-dependent E3 ligases (CDL).  The human cullin family includes six closely 
related proteins (CUL1, CUL2, CUL3, CUL4A, CUL4B and CUL5) and three distantly 
related proteins (CUL7, PARC and APC2).  All cullins contain a conserved 
carboxy-terminal domain of approximately 100 amino acids, which binds to a small RING 
finger protein: ROC1 (RING of Cullins, also known as Hrt1 and Rbx1), ROC2 or APC11 
(Deshaies, 1999; Jackson et al., 2000).  ROC proteins activate an E2 ubiquitin-conjugating 
enzyme to catalyze polyubiquitination through their RING finger, and bind with cullins 
through an N-terminal sequence flanking the RING domain to recruit the catalytic function 
of the E2 to cullins (Furukawa et al., 2002).  A unique feature of CDLs is that the cullins, 
through a conserved N-terminal domain, interact with a specificity factor — either directly 
or through an adaptor protein or adaptor complex — to recruit specific substrates, rather than 
binding to substrates directly as most other ligases do.  The SKP1 adaptor bridges an F-box 
protein to CUL1-dependent ligases (Bai et al., 1996; Feldman et al., 1997; Skowyra et al., 
1997; Zheng et al., 2002b), a heterodimeric elongins B and C complex brings VHL (von 
Hippel-Lindau) box proteins and SOCS (suppressor of cytokine signalling) box proteins to 
CUL2-dependent and CUL5-dependent ligases, respectively (Kamura et al., 2001; Kamura 
et al., 2004; Kamura et al., 1998; Stebbins et al., 1999; Zhang et al., 1999), whereas CUL3 
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binds directly to the BTB domain (Broad-Complex C (BR-C), Tramtrack (Ttk) and 
Bric-a-brac) (Furukawa et al., 2003; Geyer et al., 2003; Pintard et al., 2003; Xu et al., 2003).   
The presence of numerous substrate specificity factors — mammals express more than 60 
F-box, 40 SOCS and 200 BTB proteins — suggests that individual cullins may assemble 
into multiple E3 ligase complexes.   
 
    CUL4 has been highly conserved during evolution, with closely related orthologues 
present in fission yeast, plants, worms, flies and mammals.  Loss-of-function of the Cul4 
gene results in elongated cells with decondensed chromosomes in fission yeast (Osaka et al., 
2000) and massive DNA re-replication in C. elegans embryos (Zhong et al., 2003), and 
deletion of CUL4A results in early embryonic lethality in mice (Li et al., 2002).  Human 
CUL4A is genomically amplified or overexpressed in a portion of breast and liver tumours 
(Chen et al., 1998; Yasui et al., 2002), suggesting an oncogenic function of CUL4A.  
Loss-of-function mutation of CUL4B gene has been reported to cause a X-linked mental 
retardation syndrome (Tarpey et al., 2007; Zou et al., 2007).  Together, these results 
indicate an essential function for CUL4 (or CUL4A) in cell-cycle control, genomic stability 
and development.  Degradation of several substrates has been linked to the function of 
CUL4, including CDT1 (Higa et al., 2003; Zhong et al., 2003), HOXA9 (Zhang et al., 
2003b), STAT1 and STAT3 (Andrejeva et al., 2002; Ulane and Horvath, 2002; Ulane et al., 
2003), and c-Jun (Wertz et al., 2004).   The substrate-targeting mechanism of 
CUL4-dependent ligases is not well understood. It was recently proposed that DDB1 
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participates in targeting the substrate c-Jun to the CUL4−ROC1 ligase by interacting with an 
undefined motif present in the human De-etiolated-1 (DET1) protein (Wertz et al., 2004).  
 
      In this chapter, I report the CUL4 utilizes DDB1 and CDT2 as adaptor complex to 
target CDT1 for ubiquitination and degradation in response to DNA damage.  
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Experimental procedures  
Plasmids, cell culture and cell transfection 
Plasmids expressing, and antibodies recognizing, human CUL4A, ROC1 and CAND1, 
and procedures for yeast two-hybrid assay, immunoprecipitation and immunoblotting were 
as described (Furukawa et al., 2003; Liu et al., 2002; Ohta et al., 1999).  Plasmids 
expressing DDB1 and CDT1 were obtained from collaborators P. Raychaudhuri (University of 
Illinois at Chicago, IL) and X. Wu (Scripps Research Institute, CA). Mutations were introduced 
by site-directed mutagenesis using the Quick-Change Kit (Stratagene, La Jolla, CA) and 
verified by DNA sequencing.  All human cells were cultured in DMEM containing 10% 
FBS in a 37 °C incubator with 5% CO2.  Cell transfections were performed using a 
calcium-phosphate buffer. 
 
Antibodies, proteins, immunological procedures and mass spectrometric analysis 
    Antibodies to haemagglutinin (HA) (12CA5; Boehringer-Mannheim, Mannheim, 
Germany), to Myc (9E10; NeoMarker, Fremont, CA), to T7 (Novagen, Madison, WI), to 
FLAG (M2; Sigma, St Louis, MO) and to CSN5 (JAB1-2A10.8; GeneTex, San Antonio, TX) 
were purchased.   Rabbit polyclonal antibody to ROC1 has been described (Ohta et al., 
1999) and rabbit polyclonal antibodies to CUL4A (N-MADEAPRKGSFSALVGRTNG-C), 
CDT1 (N-ADLAHITARLAHQTRAEEGL-C) and DDB1 (N-REKEFNKGPWKQENVE-H) 
were raised against a synthetic peptide derived from the respective human proteins.  The 
rabbit polyclonal antibody to GST−CDT1 (amino acids 267−546) was a gift from X. Wu 
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(Scripps Research Institute, CA).  The rabbit polyclonal antibody to CDT2 was a gift from 
H. Zhang (Yale University, CT).  DDB1 protein purified from insect cells was a gift from N. 
Zheng (University of Washington, WA).  Procedures for protein purification, 
immunoprecipitation and immunoblotting have been described (Furukawa et al., 2003; Ohta 
et al., 1999).  To purify the endogenous ROC1 complex, HeLa cells were lysed with a 0.5% 
NP-40 lysis buffer and lysates were pooled.  To purify the CUL4A complex, 24  150-mm 
plates of BT474 breast cancer cells were lysed with a 0.5% NP-40 lysis buffer and lysates 
were pooled (150 mg total).  Lysates were incubated with affinity purified anti-ROC1 (18 
μg) or anti-CUL4A (3 μg) antibodies.   Immunocomplexes were precipitated by Protein-A 
or Protein-G agarose beads and then eluted by incubating with a molar excess of antigen 
peptide. Eluted immunocomplexes were resolved on an SDS−PAGE gel, stained with 
Coomassie blue and protein bands digested with trypsin before mass spectrometric analysis 
at the University of North Carolina Proteomics Core Facility. 
 
RNA interference 
     All siRNA oligonucleotides were synthesised with 3' dTdT overhangs by Dharmacon 
(Lafayette, CO) in a purified and annealed duplex form. The sequences targeting each 
human gene were as follows: Ddb1, 5'-CCUGUUGAUUGCCAAAAAC-3'; Ddb2, 
5'-GAGCGAGAUCCGAGUUUAC-3'; CUL4A, 5'-GAACUUCCGAGACAGACCU-3'; 
Cul4B, 5'-AAGCCUAAAUUACCAGAAA-3'; Cand1, 
5'-AATGATTTGATGACGGAACTG-3'; Cdt2, 
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5’-CAAUGGACACCAGAACUCUACCUUU -3’. OPTI-MEM medium (500 μl) was mixed 
with Lipofectamine 2000 reagent (10 μl) for 5 min and then incubated with 10 μl (20 mM) 
of siRNA for 20 min at room temperature.  DMEM−10%-FBS medium (1.5 ml) was added 
to the mixture, and the entire 2.5 ml was added to HeLa cells cultured on a 60-mm plate at 
30−40% confluency. The cells were transfected once with CUL4A, Ddb1, Cdt2 and Ddb2 
siRNA and analysed 48−72 h after transfection, and transfected three times with Cand1 
siRNA every 24 h and analysed 24 h after the last transfection. 
 
In vitro ubiquitin ligation assays. 
    The procedures for ubiquitin labeling were as described(Furukawa et al., 2003; Liu et 
al., 2002).  Briefly, to purify substrate, Myc-tagged CDT1 was ectopically expressed in 
293T cells, extracted in RIPA lysis buffer (50 mM Tris-HCl at pH 8.0, 150 mM NaCl, 1% 
NP-40, 0.5% DOC and 0.1% SDS), and immunoprecipitated using an anti-Myc antibody.  
To purify CUL4A ligases from HeLa cells, CUL4A immunocomplexes were 
immunoprecipitated using a CUL4A antibody from untreated cells or HeLa cells transfected 
with Ddb1 or Ddb2 siRNA oligonucleotides, immobilised on protein A−agarose beads and 
washed three times with an NP-40 buffer (50 mM Tris-HCl at pH 7.5, 150 mM NaCl, 0.5% 
NaCl and 50 mM NaF) and twice with a ligase assay buffer (25 mM Tris-HCl at pH 7.5, 50 
mM sodium chloride, 1 mM EDTA, 0.01% NP-40 and 10% glycerol).  For the in vitro 
CDT1 ubiquitination, the CUL4A immunocomplex was mixed with Myc−CDT1 substrate 
and the mixtures were added to a ubiquitin ligation reaction (final volume 30 μl) containing 
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the following: 50 mM Tris-HCl at pH 7.4, 5 mM MgCl2, 2 mM sodium fluoride, 10 nM 
okadaic acid, 2 mM ATP, 0.6 mM dithiothreitol, 12 μg bovine ubiquitin, 1 μg HA−ubiquitin 
(Sigma), 60 ng E1, 300 ng E2 (hUbc5c), 5 μg Myc peptide and 5 μg CUL4A peptide.  
Reactions were incubated at 37 °C for 60 min, terminated by boiling for 5 min in an SDS 
sample buffer containing 0.1 M dithiothreitol and resolved on an SDS−PAGE gel before 
immunoblotting with the anti-CDT1 antibody to examine ubiquitin ladder formation. 
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Results 
DDB1 associates with ROC1 and CUL4A in vivo 
    Our initial investigation into the function of DDB1 in CUL4−ROC1 ligases was 
inspired by the co-purification of DDB1 with ROC1 from HeLa cells (Figure 2.1A).  As 
previously reported, transfection-immunoprecipitation assays demonstrated that when 
overexpressed, DDB1 readily associates with both CUL4A and CUL4B (Shiyanov et al., 
1999) and data not shown).  To view quantitatively the DDB1−CUL4A association in vivo, 
I immunopurified an endogenous CUL4A complex from HeLa cells, which express a high 
level of CUL4A, and visualized the CUL4A complex by silver staining.  CUL4A associated 
nearly stoichiometrically with DDB1, and associated abundantly with subunits of the COP9 
signalosome (Figure 2.1B), indicating that DDB1 is a major partner of CUL4A.  In the 
same purification, as in ROC1 immunopurification from HeLa cells, we did not detect any 
DDB2.  This indicates that DDB2, if associated with DDB1−CUL4A in HeLa cells, is 
present as a minor component. 
 
DDB1 binds to an N-terminal region in CUL4A 
    To gain mechanistic insight into the DDB1−CUL4A interaction, I took advantage of the 
defined functions of different domains in cullins, and determined what sequence in CUL4A 
is involved in binding with DDB1.  Deletion of the N-terminal 97 residues in CUL4A (
N97) completely abolished DDB1 binding.  Conversely, a fragment of CUL4A retaining 
the N-terminal 406 residues (N406) exhibited a DDB1-binding activity that is similar to that  
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Figure 2.1 DDB1 associates with ROC1 and CUL4A in vivo. 
 
(A) Clarified lysates derived from HeLa cells were immunoprecipitated with an anti-ROC1 
antibody and resolved on an SDS−PAGE gel before silver staining. Specific 
ROC1-interacting proteins were identified by being competed off after addition of a molar 
excess of antigen peptide. The identities of proteins determined by mass spectrometric 
analysis are indicated. 
 
(B) An anti-CUL4A immunoprecipitate derived from 150 mg of clarified lysate from 
logarithmically growing HeLa cells was resolved by SDS−PAGE before Sypro Ruby 
staining. Specific bands were excised and subjected to mass spectrometric analysis; the 
identified proteins are indicated. 
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Figure 2.2 DDB1 binds to an N-terminal region in CUL4A. 
 
Various deletion mutants and site-specific mutants in the H2, H5 or both H2 and H5 helices 
of CUL4A were ectopically expressed in 293T cells by transient transfection, and assayed 
for binding with DDB1 by immunoprecipitation and western blot analysis. Asterisks indicate 
individual deletion mutants of myc-tagged CUL4A (A, middle). The concentration of 
endogenous DDB1 in each transfected cell population was determined by direct 
immunoblotting (B, bottom). 
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of wild-type CUL4A (Figure 2.2A).  Hence, an N-terminal sequence in CUL4A is both 
necessary and sufficient for binding to DDB1.  Two hydrophobic helical surfaces in the 
N-terminal tip of CUL1, H2 and H5 pack with hydrophobic and polar residues from SKP1 to 
form a large interface.  The N-terminal regions of other cullins form similar H2 and H5 
helices, which contain residues that are invariably conserved in orthologues, but are different 
in paralogues (Zheng et al., 2002b).  The substitution of residues in the H2 (from Leu 
86-Tyr 87-Gln 88-Ala 89-Val 90 to Ala 86-Ala 87-Ala 88-Ala 89-Ala 90) or H5 (from Trp 
139-Gln 140-Asp 141-His 142 to Ala 139-Ala 140-Asp 141-Ala 142) helices of CUL4A 
substantially reduced DDB1−CUL4A binding (Figure 2.2B).  Together, these results 
demonstrate that DDB1 binds to CUL4A in a manner similar to SKP1−CUL1 binding. 
 
DDB1 and CAND1 bind to CUL4A in a mutually exclusive manner 
     Mutations in either the H2 or H5 helices also abolished the CAND1−CUL4A 
association (Figure 2.2B), suggesting that CAND1 and DDB1 may competitively bind to an 
overlapping sequence in CUL4A.  Supporting this idea, no CAND1 was detected in the 
DDB1 immunocomplex; and conversely no DDB1 was detected in the CAND1 
immunocomplex, under conditions where CUL4A was readily detected in both DDB1 and 
CAND1 complexes (Figure 2.3A).  Notably, DDB1 associated with both unneddylated and 
neddylated forms of CUL4A, whereas CAND1 selectively associated with unneddylated 
CUL4A.  Suppression of DDB1 expression by RNA interference (RNAi) considerably 
increased the CAND1−CUL4A association, whereas it had little effect on the steady state 
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level of either protein (Figure 2.3B).  Conversely, knocking down CAND1 by RNAi did not 
affect the steady state levels of CUL4A and DDB1, but did increase the CUL4A−DDB1 
association (Figure 2.3C).  The competitive interaction between CAND1 and DDB1 for 
binding with CUL4A is very similar to the competitive interaction between CAND1 and 
SKP1 for binding with CUL1 (Liu et al., 2002), providing additional evidence that DDB1 
binds to CUL4A in a similar manner to SKP1−CUL1 binding. 
DDB1 binds to CDT1 and bridges CDT1 to CUL4A 
     To test whether DDB1 might function as a linker for CUL4A−ROC1 ligases to recruit 
substrates, I examined the possibility that DDB1 may target CDT1 for CUL4-mediated 
ubiquitination.  The DDB1−CDT1 association can be detected readily and reciprocally by 
coupled transfection and co-immunoprecipitation assays (Figure 2.4A).  Although DDB1 
binds to both fast- and slow-migrating forms of CDT1, it preferentially associated with a 
slow-migrating form of CDT1 (Figure 2.4A), which may correspond to phosphorylated 
CDT1 (Li et al., 2003).  When overexpressed in cultured human cells, CDT1 and CUL4A 
did not appreciably associate with each other, but a CDT1−CUL4A complex became readily 
detectable when these two proteins were co-expressed with DDB1 (Figure 2.4B). I postulate 
that the CDT1−CUL4A association bridged by endogenous DDB1 may be rapidly 
dissociated after ubiquitination and thus escape detection.  However, the high 
concentrations of the CDT1−DDB1−CUL4A ternary complex assembled in cells 
overexpressing all three proteins might saturate endogenous components (for example, 
ROC1) required for rapid ubiquitination and degradation of CDT1. 
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Figure 2.3 DDB1 and CAND1 bind to CUL4A in a mutually exclusive manner. 
(A) Total cell lysates were prepared from 293T cells transiently transfected with a plasmid 
expressing either T7−DDB1 or Myc−CAND1 and subjected to either direct immunoblotting 
or immunoprecipitation and western blot analysis with the indicated antibodies. (B, C) Total 
cell lysates were prepared from cells transiently transfected with siRNA silencing the 
expression of either DDB1 or CAND1. The level of individual proteins was determined by 
direct immunoblotting and CUL4A−DDB1 and CUL4A−CAND1 complexes were examined 
by immunoprecipitation and western blot analysis. 
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DWD protein CDT2 functions as a receptor to recruit substrates to CUL4-DDB1 ligase 
     In a recently published paper "DDB1 functions as a linker to recruit receptor WD40 
proteins to CUL4–ROC1 ubiquitin ligases" (He et al., 2006), my colleagues and I described 
that proteins containing a DWD (DDB1 binding WD40) motif function as receptors to recruit 
various substrates to CUL4-DDB1 ligase (Figure 2.5A).  CDT2 is a DWD protein, and it is 
under the regulation of the same transcription factor of CDT1, Cdc10 (Hofmann and Beach, 
1994), and it has been reported to associate with CDT1 in fission yeast, Xenopus and human 
(Higa et al., 2006a; Higa et al., 2006b; Jin et al., 2006; Ralph et al., 2006; Sansam et al., 2006).  
IP-western assay in mammalian cells with overexpressed CUL4A, CUL4B, DDB1 or/add 
CDT2 showed that CDT2 associates stably with CUL4A, CUL4B and DDB1, suggesting that 
CDT2 is a receptor protein for CUL4-DDB1 ligase (Figure 2.5B).  Consistent with the notion 
that CDT2 might target CDT1 to CUL4-DDB1 ligase, overexpressed CDT2 destabilized 
steady state level CDT1 (Figure 2.5B). 
CUL4, DDB1 and CDT2 are required for degradation of CDT1 in response to DNA damage 
     Consistent with a recent report that CDT1 is degraded by the CUL4−ROC1 ligases 
after DNA damage (Higa et al., 2003), UV irradiation caused rapid degradation of CDT1 in a 
proteasome-dependent manner (Figure 2.6A).  Knocking down expression of both CUL4A 
and CUL4B, prevented UV-induced CDT1 degradation, but had no detectable effect on 
CDT1 degradation in the absence of DNA damage (Figure 2.6C).  Remarkably, knocking 
down CDT2 and DDB1 effectively prevented UV-induced CDT1 degradation, but had no 
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discernible effect on the concentration of CDT1 in non-irradiated cells (Figure 2.6B, C).  In 
addition, knocking down DDB2 expression had no appreciable effect on the concentration of 
CDT1 in the presence or absence of DNA damage (Figure 2.6C).  We noted that DDB2 
itself was decreased to a nearly undetectable level after UV irradiation (Figure 2.6C); 
however, the significance and mechanism underlying the UV-induced DDB2 decrease 
remains to be determined.  
 
 
 
 
 
 
 
 
Figure 2.4 DDB1 binds to CDT1 and bridges CDT1 to CUL4A.  
 
(A) Total 293T-cell lysates prepared from cells co-transfected with plasmids expressing both 
T7−DDB1 and Myc−CDT1 were analysed for DDB1−CDT1 association by 
immunoprecipitation and western blot analysis. Note that DDB1 preferentially associates 
with the slower migrating (most probably phosphorylated) form of CDT1.  (B) The 
association of CUL4A and CDT1 was examined by immunoprecipitation and western blot 
analysis in 293T cells ectopically transfected with plasmids expressing both proteins with or 
without additional co-expression of DDB1. The levels of ectopically expressed CDT1 in 
each transfected cell population were determined by direct immunoblotting of the same cell 
lysates (bottom). 
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Figure 2.5 CDT2 functions as a receptor for CUL4-DDB1 ligase to target CDT1.  
 
(A) CUL4-DDB1 ligase utilizes DWD (DDB1 binding WD40) proteins as receptors to target 
substrates. (B) 293T cells were transfected with plasmids expressing T7-DDB1, Flag-CDT2, 
Myc3-CUL4A or/and Myc3-CUL4B. Cell lysates were immunoprecipitated by anti-Flag 
antibody. The levels of proteins were detected by anti-Myc, anti-Flag, anti-DDB1, 
anti-tubulin and anti-CDT1 antibodies. 
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 CUL4, DDB1 and CDT2 are required for ubiquitination of CDT1 in vitro 
     The CUL4A as well as CUL4B and CDT2 immunocomplexes efficiently catalyzed 
polyubiquitination of CDT1 in vitro in an E1- and E2-dependent manner (Figure 2.7A and 
C).  Deletion of either the N-terminal 203 or 97 residues from CUL4A, which disrupted 
DDB1−CUL4A association, abolished the ability of the CUL4A immunocomplex to 
ubiquitinate CDT1.  Knocking down DDB1, but not DDB2, by RNAi substantially reduced 
the efficiency of CUL4A-catalyzed CDT1 polyubiquitination (Figure 2.7B).   Together, 
these results indicate that DDB1 and CDT2 are required for UV-induced CDT1 degradation 
in vivo and CUL4A-mediated CDT1 ubiquitination in vitro.  DDB2 has long been linked 
with DDB1 functionally, and forms a complex with DDB1 (Keeney et al., 1993).  The 
exact role of DDB2 in connection with CUL4 remains unclear, but it has been suggested to 
be a substrate of, or to recruit substrates to, the DDB1−CUL4 ligase (Groisman et al., 2003; 
Nag et al., 2001).  My results also suggest that DDB2 has only a minor, if any, role in 
mediating CDT1 ubiquitination by the DDB1−CUL4A−ROC1 ligase in response to UV 
irradiation.  This notion is supported by the fact that DDB2 is not present in non-mammals, 
whereas the other five components (DDB1, CUL4, CDT2, ROC1 and CDT1) are 
evolutionarily conserved. 
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Figure 2.6 CUL4, DDB1 and CDT2 are required for the degradation of CDT1 in 
response to DNA damage 
 
(A) UV irradiation induced a rapid and proteasome-dependent degradation of CDT1. HeLa 
cells were irradiated by UV (50 J/m2) with or without MG132 treatment. The level of CDT1 
protein was determined by direct immunoblotting of total-cell lysate prepared 30 min after 
UV treatment. (B, C) CUL4, DDB1 and DCT2 are required for the UV-induced rapid 
degradation of CDT1. HeLa cells were transfected with siRNA oligonucleotides silencing 
CDT2, DDB1, DDB2 or a combination of both CUL4A and CUL4B. Cells were 
UV-irradiated (50 J/m2) 48 h after transfection and then lysed for 30 min. The steady state 
levels of CDT1, as well as CDT2, DDB1, DDB2 and CUL4A, were determined by direct 
immunoblotting. 
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Figure 2.7 CUL4, DDB1 and CDT2 are required for the ubiquitination of CDT1 in vitro 
 
(A) The N-terminal sequence of CUL4A is required for in vitro CDT1 ubiquitination. 
Myc-tagged wild-type and mutant CUL4A were ectopically expressed in 293T cells, 
immunoprecipitated using an anti-Myc antibody and incubated with separately precipitated 
Myc−CDT1 from transfected 293T cells in the presence or absence of various components 
as indicated. The Myc antigen peptide was added to the mixtures to elute the ligases and the 
substrates. The ubiquitination reaction mixtures, as well as the eluate (middle) and proteins 
remaining on the protein G agarose beads (bottom), were resolved on an SDS-PAGE gel, 
before immunoblotting with an anti-CDT1 or anti-Myc antibody. (B) DDB1 is required for 
in vitro CUL4A-mediated ubiquitination of CDT1. The CUL4A immunocomplex was 
precipitated from untransfected HeLa cells or HeLa cells transfected with siRNA 
oligonucleotides silencing DDB1 or DDB2. The targeted reduction of DDB1 or DDB2 
expression was verified by direct immunoblotting (bottom). The substrate, Myc−CDT1, was 
immunoprecipitated from separately transfected 293T cells and incubated with the CUL4A 
immunocomplex in the presence or absence of various components as indicated. A CUL4A 
peptide and the Myc peptide were added to the mixtures to elute the ligases and the 
substrates, respectively. After an in vitro ubiquitination reaction, the mixtures were resolved 
on an SDS−PAGE gel and CDT1 ubiquitination was examined by immunoblotting with an 
anti-CDT1 antibody (top). (C) CDT2 is required for in vitro CDT1. Myc-tagged CUL4A and 
CUL4B and Flag-tagged CDT2 were ectopically expressed in 293T cells, 
immunoprecipitated using an anti-Myc or anti-Flag antibodies and incubated with separately 
precipitated HA-CDT1 from transfected 293T cells in the presence or absence of various 
components as indicated. The Myc, Flag or HA antigen peptide was added to the mixtures to 
elute the ligases and the substrates. The ubiquitination reaction mixtures were resolved on an 
SDS-PAGE gel, before immunoblotting with an anti-HA antibody.  
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Discussion 
    DDB1 was first discovered as a component of the damaged DNA binding protein 
complex (DDB), which contains the other component DDB2, using a two-step 
chromatographic purification composed of a hydroxylapatite column and an UV-irradiated 
DNA cellulose column (Takao et al., 1993).  DDB2 mutations have been linked to 
xeroderma pigmentosum Group E, a human hereditary disease characterized by defective 
nucleotide excision repair and increase of skin cancer (Dualan et al., 1995; Rapic-Otrin et al., 
2003).  DDB1 mutation, on the other hand, has not been identified in any xeroderma 
pigmentosum patients.  The role of DDB1 in DNA repair has been elusive for quite a long 
time after multiple contradictory studies (Li et al., 2006a; Reardon and Sancar, 2003; 
Wakasugi et al., 2002; Wakasugi et al., 2001; Wittschieben et al., 2005).  My work shows 
that the major function of DDB1 is an adaptor for CUL4 to target substrates for 
ubiquitination.  There are four lines of evidence supporting the conclusion that DDB1 plays 
a role as a major adaptor in CUL4 complex to target substrates, CDT1 specifically, for 
ubiquitination: first, DDB1 binds stochiometrically with CUL4A in vivo; second, 
CUL4A-DDB1 association is negatively regulated by CAND1 in a manner similar with 
CUL1-SKP1 association; third, depletion of DDB1 abolishes the degradation of CDT1 in 
response DNA damage; finally, depletion of DDB1 decreases the ubiquitination level of 
CDT1 catalyzed by CUL4A immunocomplex in vitro.  
     One remarkable feature of CUL1-, CUL2- and CUL3-dependent ligases is the 
assembly of various distinct complexes through interaction with a common motif present in 
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multiple adaptor proteins.  To look for the specificity factors of CUL4-DDB1 ligase, 
Yizhou He, a former technician in our lab, aligned four reported CUL4-DDB1 associating 
WD40 proteins, including DDB2, RbBP7, CSA and COP1.  He found that there is a 
common motif in these four WD40 proteins, and this motif is not present in another WD40 
protein CDC20 which does not bind to CUL4-DDB1.  We named this motif DWD (DDB1 
binding WD40) (He et al., 2006).  He searched other WD40 proteins and found over 100 
containing DWD motif and he picked 12 of them to test the bindings with CUL4-DDB1.  
IP-western assays showed that all these 90 DWD proteins bind to CUL4-DDB1, suggesting 
that CUL4-DDB1 utilize DWD proteins as receptors to target various substrates.  My work 
demonstrated that CDT2 is a DWD protein which is required for CDT1 uibuiqintation and 
degradation in response to DNA damage, which supports Yizhou's conclusion.  
    DDB1 is conserved from fission yeast to human.  Deletion of DDB1 gene in fission 
yeast causes genomic instability, increase of spontaneous mutation rate and failure to pass 
the meiosis (Bondar et al., 2003; Bondar et al., 2004; Holmberg et al., 2005).  Deletion of 
DDB1 in Drosophila leads to early developmental lethality (Takata et al., 2002).  
Inactivation CUL4 or DDB1 in C. elegans causes CDT1 accumulation and DNA 
re-replication (Kim and Kipreos, 2006; Zhong et al., 2003).  Deletion of CUL4A (Li et al., 
2002) or DDB1 (Cang et al., 2006) in mice leads to early embryonic lethality.  Deletion of 
DDB1 in mouse brain, lens and epidermis causes genomic instability and apoptosis in 
proliferating progenitor cells.  Removal of p53 rescues the lethality of many mitotic cells 
from death and allows them proliferate aberrantly (Cang et al., 2006).  
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    Since the first substrate CDT1 was identified, CUL4-DDB1 has been shown to 
ubiquitinate multiple substrates.  Paramyxovirus V proteins have been reported to hijack 
CUL4-DDB1 to ubiquitinate and degrade STAT1/3 (Ulane and Horvath, 2002; Ulane et al., 
2003).  C-Jun, an oncogene is recruited to CUL4-DDB1 by DET1-COP1 complex for 
ubiquitination (Wertz et al., 2004).  CDT2 targets not only CDT1 but also Spd1, an 
inhibitor of ribonucleotide reductase in S. pombe (Bondar et al., 2004; Liu et al., 2005).  
The ubiquitination catalyzed by CUL4-DDB1 is involved in not only proteasome-dependent 
degradation, but also in non-protealytic regulation.  CUL4-DDB1 has been reported to 
target XPC (El-Mahdy et al., 2006) and histones (Kapetanaki et al., 2006; Wang et al., 2006) 
for non-protealytic ubiquitination through receptor DDB2.  The polyubiquitination chain 
through the linkage on K48 of ubiquitin is believed to be transported to proteasome, while 
K63 polyubiquitin chain is involved in proteasome independent regulation.  How 
CUL4-DDB1 ligase catalyzes both types of polyubiquitin chain remains intriguing.  
HOXA9 (Zhang et al., 2003a) and p27 (Bondar et al., 2006) were also reported to be 
substrates of CUL4-DDB1.  
    CDT1 is a DNA replicative licensing factor.  The degradation of CDT1 in response to 
DNA damage prevents the aberrant DNA replication and serves a novel checkpoint.  CDT1 
is also degraded during the S and G2 phases of the cell cycle.  However, my study showed 
that CUL4 and DDB1 RNAi did not accumulate CDT1 in the absence of DNA damage 
reagent.  Recently, Nishitani reported that during the S and G2 phases of the cell cycle, 
CDT1 is ubiquitinated by two redundant ubiquitin ligases CUL4-DDB1 and SCF-SKP2 in 
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mammalain cells (Nishitani et al., 2006).  Later in the third chapter, I will show that in 
fission yeast, the degradation of CDT1 in the normal cell cycle is only dependent on 
CUL4-DDB1, but not SCF-SKP2, suggesting that SCF-SKP2 are evolved later to ensure the 
precise regulation of CDT1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
                                                 46 
 
 
Chapeter III 
   
PCNA IS REQUIRED FOR CDT1 DEGRADATION BY 
CUL4-DDB1-ROC1 IN RESPONSE TO DNA DAMAGE 
 
(Including modified portions of “An evolutionarily conserved function of proliferating cell 
nuclear antigen for CDT1 degradation by the Cul4-Ddb1 ubiquitin ligase in response to DNA 
damage,” Jian Hu and Yue Xiong, J Biol Chem. 2006 Feb; 281(7):3753-6.) 
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Summary 
    The DNA replication licensing factor CDT1 is degraded by the ubiquitin-proteasome 
pathway during S phase of the cell cycle, to ensure one round of DNA replication during 
each cell division and to halt DNA replication in response to DNA damage.  Constitutive 
expression of CDT1 causes DNA re-replication and is associated with the development of a 
subset of human non-small cell-lung carcinomas. In mammalian cells, DNA 
damage-induced CDT1 degradation is catalyzed by the CUL4-DDB1-ROC1 E3 ubiquitin 
ligase. We report here that overexpression of the proliferating cell nuclear antigen (PCNA) 
inhibitory domain from the CDK inhibitors p21 and p57, but not the CDK-cyclin inhibitory 
domain, blocked CDT1 degradation in cultured mammalian cells after UV irradiation.  In 
vivo soluble CDT1 and PCNA co-elute by gel filtration and associate with each other 
physically.  Silencing PCNA in cultured mammalian cells or repression of pcn1 expression 
in fission yeast blocked CDT1 degradation in response to DNA damage. Unexpectedly, 
deletion of Ddb1 in fission yeast also accumulated CDT1 in the absence of DNA damage. 
We suggest that the CUL4-DDB1 ligase evolved to ubiquitinate CDT1 during normal cell 
growth as well as in response to DNA damage and a separate E3 ligase, possibly SCF(Skp2), 
evolved to share the function of CDT1 ubiquitination during normal cell growth and that 
PCNA is involved in mediating CDT1 degradation by the CUL4-DDB1 ligase in response to 
DNA damage. 
 
 
   
                                                 48 
Background 
    CDT1, first identified in the fission yeast Schizosaccharomyces pombe as a G1 START 
component Cdc10-dependent transcript whose loss-of-function prevents DNA replication 
(Hofmann and Beach, 1994), binds to the origin recognition complex (ORC) with Cdc6 at 
the origins of replication and together with Cdc6 and ORC recruits the minichromosome 
maintenance 2–7 (MCM2–7) to assemble the prereplication complexes during G1, thereby 
controlling the initiation of DNA replication (Bell and Dutta, 2002).  Constitutive 
expression of CDT1 alone in Caenorhabditis elegans, with Cdc6 in S. pombe or with Cdc6 
and cyclin A-cdk2 in p53-deficient mammalian cells causes DNA re-replication (Vaziri et al., 
2003; Yanow et al., 2001; Zhong et al., 2003).  Constitutive expression of CDT1 is also 
associated with the development of a subset of human non-small lung carcinomas 
(Karakaidos et al., 2004), indicating the critical importance of regulating CDT1 level for 
both initiating DNA replication and maintaining genome integrity.  
     In addition to Cdc10-dependent transcriptional regulation, at least four mechanisms 
have been proposed for controlling CDT1 function at the protein level: CDT1 is exported 
from the nucleus in S phase in the budding yeast Saccharomyces cerevisiae (Tanaka and 
Diffley, 2002), is inhibited by the binding of geminin from S to M phase in metazoans 
(Wohlschlegel et al., 2000), is degraded in human cell lines, possibly by the SCFSkp2 E3 
ubiquitin ligase (Li et al., 2003; Nishitani et al., 2000), and is degraded in response to DNA 
damage and during normal C. elegans embryogenesis by the CUL4-DDB1-ROC1 ubiquitin 
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E3 ligase (Higa et al., 2003; Hu et al., 2004; Zhong et al., 2003).  Evolving multiple distinct 
mechanisms to negatively regulate the level of CDT1 protein presumably functions to meet 
the needs of stopping DNA replication irreversibly at multiple stages of the cell cycle and 
development and rapidly in response to genotoxic insults.  
    The mechanisms underlying the ubiquitin-mediated degradation of CDT1 remain 
incompletely understood.  In particular, the identity and components of the CDT1 E3 
ubiquitin ligase are currently confusing.  Two different E3 ligases, a CUL1-dependent 
SCFSkp2 E3 (Li et al., 2003; Sugimoto et al., 2004) and a CUL4-DDB1-dependent E3 (Higa 
et al., 2003; Hu et al., 2004; Zhong et al., 2003), have been linked to CDT1 degradation.  
Critically missing from the current understanding of these two ligases in promoting CDT1 
ubiquitination is the signal(s) that recruits CDT1 to either ligase.  I described in the Chapter 
II that DDB1 preferentially associated with a slow migrating form of CDT1, which likely 
corresponds to phosphorylated CDT1.  The nature of this DNA damage-induced CDT1 
kinase and whether CDT1 phosphorylation is required for binding with DDB1 are yet to be 
determined.  Separately, a cyclin A-dependent CDK has been reported to promote CDT1 
phosphorylation and subsequent binding with the F-box protein Skp2 (Liu et al., 2004; 
Sugimoto et al., 2004), resulting in CDT1 degradation during the normal cell cycle.      
     Co-immunoprecipitation analysis showed that cells treated with the proteasome 
inhibitor MG132 prior to UV irradiation had increased Skp2-CDT1 association (Kondo et al., 
2004), raising the possibility that both SCFSkp2 and CUL4-DDB1 could mediate CDT1 
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degradation following UV-induced DNA damage.  In an effort to clarify the role of CDKs 
in regulating CDT1 ubiquitination, I examined how CDK inhibitors may affect CDT1 
degradation during the DNA damage response.  This investigation did not identify any 
evidence for the requirement of a CDK in regulating CDT1 degradation in response to DNA 
damage but instead led to the unexpected finding that the proliferating cell nuclear antigen 
(PCNA) is required for CDT1 degradation.  
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Experimental procedures  
Plasmids, Cell Culture, and Cell Transfection 
    Plasmids expressing human p21, p21ΔPCNA (M148A/F151A), p27, p57QT(residues 
142–198), and p57QTΔPCNA (L271A/F275A) were described previously (Watanabe et al., 
1998), and the procedures for immunoprecipitation and immunoblotting were as described in 
the Chapter II.  All human cells were cultured in Dulbecco's modified Eagle's medium 
containing 10% fetal bovine serum in a 37 °C incubator with 5% CO2.  Cell transfections 
were performed using a calcium phosphate buffer.  
Antibodies, Proteins, Immunological Procedures, Mass Spectrometric Analysis, and Size 
Exclusion Chromatography 
    Antibodies to hemagglutinin (HA) (12CA5; Roche Applied Science, Mannheim, 
Germany), to protein A (Sigma), to PCNA (PC10, Santa Cruz Biotechnology, Santa Cruz, 
CA), to actin (NeoMarkers, Fremont, CA), and to p21, p27, and p57 (Foster and Galloway, 
1996; Watanabe et al., 1998) were either purchased commercially or described previously.  
Rabbit polyclonal antibodies to CUL4A, Ddb1, and CDT1 have been described in the 
Chapter II.  To purify the CDT1 complex, 10 150-mm plates of HEK 293T cells were 
transfected with pcDNA3-myc3-CDT1 and lysed with a 0.5% Nonidet P-40 lysis buffer (50 
mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 50 mM NaF).  Pooled lysates 
were incubated with affinity purified anti-CDT1 (10 µg) antibody.  Immunocomplexes 
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were precipitated by protein A-agarose beads and then eluted by incubating with a molar 
excess of antigen peptide. Eluted immunocomplexes were resolved on an SDS-PAGE gel, 
stained with Coomassie Blue, and protein bands digested with trypsin before mass 
spectrometric analysis at the University of North Carolina-Duke Proteomics Core Facility.  
For size exclusion chromatography, HeLa cells were lysed in 0.5% Nonidet P-40 lysis buffer 
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Nonidet P-40, 50 mM NaF) and fractionated 
on a Sepharose 200 gel-filtration column.  The fractions were resovled by SDS-PAGE 
before the levels of CDT1 and PCNA were determined by immunoblotting.  
RNA Interference 
    All siRNA oligonucleotides were synthesized with 3'-NN overhangs by Dharmacon 
(Lafayette, CO) in a purified and annealed duplex form. The sequences targeting each 
human gene were as follows: Ddb1, 5'-CCUGUUGAUUGCCAAAAAC-3' and PCNA, 
5'-UCAAGGACCUCAUCAACGA-3'. Opti-MEM medium (500 µl) was mixed with 
Lipofectamine 2000 reagent (10 µl) for 5 min and then incubated with 10 µl (20 mM) of 
siRNA for 20 min at room temperature. Dulbecco's modified Eagle's, 10% fetal bovine 
serum medium (1.5 ml) was added to the mixture, and the entire 2.5 ml was added to HeLa 
cells cultured on a 60-mm plate at 30–40% confluence.  
S. pombe Genetics and Strain Construction  
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    Strain construction, gene deletion, and epitope tagging were performed by standard 
genetic techniques (Bahler et al., 1998).  Nmt81-Pcn1 was a gift from Dr. Teresa Wang of 
Stanford University (Arroyo and Wang, 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
                                                 54 
Results 
Inhibition of PCNA by p21 or p57 prevents the degradation of CDT1 in response to UV 
    To determine how CDK activity may affect CDT1 degradation in response to DNA 
damage, I overexpressed the CDK inhibitors p21 and p27 in HEK 293T cells and determined 
the steady-state levels of CDT1 protein following UV irradiation.  Overexpression of p21 
considerably inhibited CDT1 degradation following UV irradiation (Figure 3.1A).  
Although this finding is consistent with the notion that CDK may cause CDT1 
phosphorylation and thereby promote its degradation in response to DNA damage, 
surprisingly, overexpression of p27 had no detectable effect on CDT1 degradation in the 
same experiment.  Both p21 and p27 have indistinguishable CDK substrate specificity 
regions in their N termini.  The major difference between these two CDK inhibitors lies in 
their C-terminal regions; while p21 contains a PCNA binding and inhibitory domain in its 
C-terminal region, the C-terminal sequence of p27 plays roles in regulating the 
phosphorylation of p27 and stability but has no PCNA binding activity.  This prompted us 
to determine which region in p21, the N-terminal CDK-cyclin binding or C-terminal PCNA 
binding sequence, is required for inhibiting CDT1 degradation following UV irradiation.  
    The C-terminal PCNA binding domain in p21 has been extensively characterized and 
residues required for the binding of p21 to PCNA have been identified (Chen et al., 1995; 
Luo et al., 1995; Nakanishi et al., 1995; Warbrick et al., 1995).  Combined mutations of 
Met148 and Phe151 to Ala in p21 (referred to as p21ΔPCNA) completely disrupted its binding 
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with PCNA (Nakanishi et al., 1995; Warbrick et al., 1995) and its ability to block CDT1 
degradation following UV irradiation (Figure 3.1B).  The p57KIP2 CDK inhibitor also 
contains a C-terminal domain, often referred to as the QT domain, that shares sequence 
homology with the C-terminal PCNA binding domain of p21 and binds with and inhibits the 
function of PCNA (Watanabe et al., 1998).  To further confirm the role of PCNA in 
regulating CDT1 degradation, I ectopically expressed the p57QT domain and examined 
CDT1 degradation following UV irradiation.  Overexpression of the p57QT peptide, but 
not a L271A/F275A mutant peptide (referred to as p57QTΔPCNA) that cannot bind with 
PCNA (Watanabe et al., 1998), blocked CDT1 degradation after UV irradiation (Figure 
3.1C), demonstrating that inhibition of PCNA blocked CDT1 degradation in response to 
DNA damage.  These results also indicate that CDKs that are inhibited by p21 and p27 
(CDK1–CDK6) are unlikely to be required for DNA damage-induced CDT1 degradation.  
In the absence of DNA damage, overexpression of both p21 and p27 increased the 
steady-state level of CDT1 protein, particularly the slower migrating form (Figure 3.1A).  
This observation suggests that either a p21/p27-sensitive CDK(s) is involved in regulating 
CDT1 stability during normal cell growth, or the CDT1 increase resulted indirectly from the 
G1 cell cycle arrest caused by p21 or p27 overexpression.  My subsequent study was 
focused on the control of CDT1 stability during the DNA damage response. 
PCNA and CDT1 co-exist in size exclusive fractionation 
    To obtain further evidence corroborating the function of PCNA in controlling CDT1  
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Figure 3.1 Inhibition of PCNA prevents the degradation of CDT1 in response to UV. 
 
HEK 293T cells were transfected with plasmids expressing p21 and p27 (A), a p21 mutant 
deficient in binding with PCNA (p21ΔPCNA) (B), and the PCNA binding domain of p57 
(HA-p57QT) or a mutant of p57QT deficient in PCNA binding (HA-p57QT ΔPCNA) (C). 
Cells were UV-irradiated (50 J/m2) 24 h after transfection and then lysed 30 min later. The 
steady-state levels of CDT1 as well as p21, p27, p57, Ddb1, and actin proteins were 
determined by direct immunoblotting. 
 
 
loading 
CDT1  
(short exposure) 
CDT1  
(longer exposure) 
CDT1 
p21 
UV 
1 2 3 4 5 6 
p21 p21ΔPCNA 
+++
p21ΔPCNA 
CDT1
actin
UV
1
p57QT 
+
p21 p57QTΔPCNA
2 3 4 5 6 7 8
+ + +
p57QT 
DDB1
p27
p21 
UV 
1 2 3 4 5 6 
p27 p21
+++
C
   
                                                 57 
degradation, I examined the distribution of these two proteins by gel filtration.  Size 
exclusion chromatography analyses indicated that soluble (non-chromatin-associated) PCNA 
and CDT1 co-eluted in a fraction at molecular mass of less than 158 kDa that is consistent 
with the formation in vivo of a complex containing PCNA and CDT1 (Figure 3.2).  CUL4A, 
on the other hand, is present in high molecular mass fractions and is not detected in the low 
molecular mass fractions that contain both CDT1 and PCNA.  The patterns of co-elution of 
CDT1 and PCNA and mutually exclusive distribution of PCNA-CDT1 from CUL4A are 
consistent with the possibility that PCNA is involved in promoting CDT1 ubiquitination and 
subsequent degradation of CDT1 by the CUL4A ligase. 
 
CDT1 and PCNA associate with each other in vivo 
     Using the CDT1 antibody described in Chapter II, I immunopurified CDT1 complexes 
from an Nonidet P-40-soluble extract and examined them by Coomassie blue staining 
(Figure 3.3A).  CDT1-interacting proteins were identified as the polypeptides that were 
competed off by a molar excess of antigen peptide.  In addition to a 60-kDa band that was 
identified as CDT1 (see below), the only prominent polypeptides visualized were several 
bands clustered at a molecular mass of around 35 kDa.  Mass spectrometry analyses 
identified, in addition to the 60-kDa CDT1, two proteins: geminin and PCNA (Figure 3.3B). 
The close migration of geminin and PCNA prevented us from determining the relative 
stoichiometric ratio of CDT1 and these two proteins.  Overexpression of p21 reduced the 
PCNA-CDT1 association (Figure 3.3C), suggesting that one possible mechanism by which  
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Figure 3.2 PCNA and CDT1 co-exist in size exclusion chromatography 
 
HeLa cells were lysed in 0.5% Non-idet P-40 lysis buffer and fractionated on a Sepharose 
200 gel-filtration column. The fractions were resolved by SDS-PAGE before the levels of 
CUL4A, CDT1, and PCNA were determined by immunoblotting. 
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p21 stabilizes CDT1 is to hinder PCNA-CDT1 association.  This result, however, needs to 
be interpreted cautiously as the possibility remains that p21 could also impede CDT1-PCNA 
association by inhibiting CDK-mediated CDT1 modification. 
 
PCNA is required for CDT1 degradation in response to DNA damage in mammalian cells 
    To seek in vivo evidence supporting a role of PCNA in CDT1 degradation, I first 
performed RNAi-based experiments in cultured mammalian cells to determine how silencing 
the expression of PCNA affects the steady-state level of CDT1 protein.  Consistent with the 
data presented in Chapeter II, knocking down DDB1 by siRNA accumulated CDT1 in 
UV-treated HeLa cells (Figure 3.4).  Notably, reduction of the steady-state level of PCNA 
by siRNA accumulated CDT1 following UV irradiation as well (Figure 3.4, comparing lanes 
1 and 3) but did not increase CDT1 protein level in non-irradiated cells (comparing lanes 2 
and 4).  The partial effect of PCNA RNAi on degradation of CDT1 is likely due to 
incomplete depletion of PCNA protein. 
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Figure 3.3 CDT1 and PCNA associate with each other in vivo and in vitro 
 
(A and B) an anti-CDT1 immunocomplex was purified from HEK 293T cells ectopically 
expressing myc3-CDT1 and was resolved by SDS-PAGE. After Coomassie Blue staining, 
specific bands were identified by being competed off by a molar excess of antigen peptide, 
excised, and subjected to mass spectrometric analysis. The identified peptide sequences are 
indicated, and the numbers refer to the position of the first and last amino acid residue of the 
identified peptide in the full-length protein.  (C) HEK 293T cells were transfected with 
plasmids expressing HA-CDT1 with or without p21. Cells were lysed in 0.5% Nonidet P-40 
lysis buffer, and cleared lysates were immunoprecipitated with an antibody to CDT1 (left 
panel). The steady-state levels of CDT1 and PCNA protein were determined by direct 
immunoblotting. 
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Figure 3.4 PCNA is required for CDT1 degradation in response to DNA damage in 
mammalian cells 
 
Logarithmically growing HeLa cells were transfected with siRNA oligonucleotides silencing 
DDB1 and PCNA. Cells were UV-irradiated (50 J/m2) 48 h after transfection and then lysed 
after 30 min. The steady-state levels of CDT1, as well as DDB1, PCNA, and actin, were 
determined by direct immunoblotting. 
 
 
PCNA is required for CDT1 degradation in response to DNA damage in fission yeast 
     For further in vivo experiments, I utilized fission yeast, which has conserved PCNA, 
CDT1, and the Cul4-Ddb1 E3 ligase.   I constructed fission yeast strains expressing 
TAP-tagged CDT1 under the control of its native promoters in both Ddb1+ and Ddb1Δ 
backgrounds.  The steady-state level of CDT1-TAP is much higher in Ddb1Δ than in Ddb1+ 
cells (Figure 3.5A comparing lanes 1 and 3).  This result provides the first evidence that in 
fission yeast Ddb1 is also involved in controlling CDT1 degradation as in mammalian cells 
and that a Ddb1-mediated E3 ligase in fission yeast cells also controls CDT1 degradation 
during normal cell growth in the absence of DNA damage.  I then examined the level of 
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CDT1 in CDT1-TAP, Ddb1Δ and CDT1-TAP, Ddb1+ cells sustaining either inhibition of DNA 
replication or DNA damage.  Unexpectedly, unlike DNA damage (see below), inhibition of 
DNA replication by treatment of cells with hydroxyurea (HU) increased, rather than 
decreased, the steady-state level of CDT1-TAP (Figure 3.5B, comparing lanes 1 and 2).  To 
confirm this result, we constructed yeast strains expressing TAP-tagged Spd1 (Spd1-TAP) 
under the control of its native promoters in both Ddb1+ and Ddb1Δ backgrounds.  Spd1 is an 
inhibitor of ribonucleotide reductase and is also targeted for degradation by the Cul4-Ddb1 
ligase both during S phase and in response to DNA damage in S. pombe (Bondar et al., 2004; 
Holmberg et al., 2005; Liu et al., 2003).  Consistent with previous reports, inhibition of 
DNA replication caused complete degradation of Spd1 and deletion of Ddb1 blocked 
HU-induced Spd1 degradation (Figure 3.5B, comparing lanes 1 and 3).  We also noted that 
during the normal cell cycle, the steady-state level of Spd1 is higher in Ddb1+ cells than in 
Ddb1Δ cells (Figure 3.5B, comparing lanes 2 and 4), confirming that Ddb1 in fission yeast 
cells is involved in degradation of Spd1 both during normal cell cycle and when DNA 
replication is blocked.  HU inhibits ribonucleotide reductase, and thus dNTP production, 
therefore arresting the DNA replication fork.  Our results reveal a major difference between 
CDT1 and Spd1 degradation during the normal cell cycle.  We speculate that during S 
phase, Spd1 and CDT1 are degraded before and after replication fork formation, respectively, 
and an additional factor(s) may contribute differently to the ubiquitination of these two 
proteins by the same Ddb1-mediated E3 ligase. 
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    In ddb1Δ cells, CDT1 accumulated to a much higher level (comparing lanes 1 and 3 of 
Figure 3.5A or lanes 6 and 8 in Figure 3.5C) than Spd1 (comparing lanes 2 and 4 of Figure 
3.5B), indicating that although Ddb1 is required for the degradation of both proteins, the 
level of these two proteins is regulated by an additional mechanism(s).  We postulate that 
there may exist a feedback regulatory mechanism to repress the expression of Spd1, but not 
CDT1, in ddb1Δ cells during each cycle.  As a result, CDT1 continuously accumulates to a 
very high level that, although not inhibiting cell growth, would contribute to deregulated 
DNA replication and thus genomic instability.  
    Treatment of cells with methylmethane sulfonate (MMS), a DNA damage reagent, 
caused CDT1 degradation in Ddb1+ cells (Figure 3.5C, comparing lanes 3 and 4 or lanes 5 
and 6) but had no effect on the steady-state level of CDT1 in ddb1Δ cells (lanes 7 and 8), 
indicating that DNA damage-induced, Ddb1-mediated CDT1 degradation had evolved as 
early as in yeast cells.  To investigate whether PCNA is required for CDT1 degradation in 
response to DNA damage in S. pombe, I generated a strain in which PCNA encoding gene 
Pcn1 expression is under the control of the thiamine-repressible nmt81 promoter and TAP is 
tagged after the CDT1 gene (nmt81-pcn1, CDT1-TAP).  Repression of Pcn1 expression by 
thiamine addition was confirmed by direct blotting with an antibody specific to PCNA 
(Figure 3.5C, comparing lanes 1 and 2 and lanes 3 and 4).  Loss of PCNA had no 
significant effect on the steady-state level of CDT1-TAP in the absence of DNA damage 
(comparing lanes 2 and 4) but blocked the degradation of CDT1 in response to DNA damage 
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(comparing lanes 1 and 3).  Hence PCNA is required for CDT1 degradation in response to 
DNA damage in S. pombe.  Less CDT1 was accumulated in PCNA-depleted cells than in 
Ddb1-null cells.  This is likely because depletion of PCNA arrests the cell cycle and thus 
prevents further CDT1 accumulation, while Ddb1 null cells continue to proliferate and 
accumulate CDT1. 
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Figure 3.5 PCNA is required for CDT1 degradation in response to DNA damage 
 
(A and B) S. pombe strains CDT1-TAP and CDT1-TAP, ddb1Δ or Spd1-TAP and Spd1-TAP, 
ddb1Δ were treated with 20 mM HU for 4 h or untreated. Yeast cells were collected and 
lysed with acid-washed glass beads. Steady-state levels of CDT1-TAP and Spd1-TAP 
proteins were determined by direct immunoblotting. (C) S. pombe strain nmt81-Pcn1, 
CDT1-TAP was treated with 150 mM thiamine for 12 h and then treated with 0.1% MMS for 
3 h. S. pombe strains CDT1-TAP and CDT1-TAP, ddb1Δ were treated with 0.1% MMS for 3 
h or untreated. Yeast were collected and lysed with acid-washed glass beads. Steady-state 
levels of CDT1-TAP and PCNA were determined by direct immunoblotting. 
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Discussion 
    In this study, I present three separate lines of evidence that collectively support a role of 
PCNA in mediating CDT1 degradation by CUL4-DDB1 in response to DNA damage.  First, 
overexpression of the PCNA inhibitory domain of either p21 or p57, but not the CDK-cyclin 
inhibitory domain, blocked CDT1 degradation in UV-irradiated cells.  Second, soluble 
PCNA and CDT1 co-exist in the same fractions and PCNA and CDT1 physically associate 
with each other in vivo.  Third, knocking down PCNA in cultured mammalian cells and 
repression of PCNA expression in fission yeast both block CDT1 degradation following 
DNA damage.  Together with the findings that DDB1 is required for DNA damage-induced 
CDT1 degradation in mammalian cells described in the Chapter II and in fission yeast 
(Figure 3.5C), I suggest that PCNA-dependent CDT1 degradation by CUL4-DDB1 ligase in 
response to DNA damage evolved quite early and has been conserved during evolution.  
     My study also raises three new questions.  First, what is the exact biochemical role of 
PCNA in promoting CDT1 degradation?  I previously described that DDB1 can target 
CDT1 through CDT2, suggesting that PCNA is not required for recruiting CDT1 to the 
CUL4-DDB1 ligase.  Thus far, my in vitro immunoprecipitation-based CDT1 
ubiquitination assay has neither identified a significant amount of PCNA nor revealed a role 
of PCNA in CDT1 ubiquitination by the CUL4-DDB1 ligase.  One factor obviously 
missing from these assays is subcellular localization.  In particular, given that all four 
proteins, CDT1, PCNA, DDB1, and CUL4, are associated with chromatin, it is likely that 
CDT1 ubiquitination may occur in situ at the site of damaged DNA on chromatin and that 
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PCNA plays a critical role in bringing about in situ CDT1 ubiquitination, a function that is 
not possible to be detected in the current in vitro assay or by reconstitution.  In fact, in 
Xenopus, CDT1 is degraded during the course of DNA replication on chromatin (Arias and 
Walter, 2005).  Whether this replication-dependent CDT1 degradation on chromatin is 
catalyzed by the CUL4-DDB1 ligase or regulated by CDK remains to be determined.  
    The second issue concerns the role of DDB1, a factor that was initially identified as a 
component of a damaged DNA binding activity and has long been associated with DNA 
repair processes, during normal cell growth in the absence of DNA damage.  Surprisingly, 
deletion of Ddb1 in fission yeast cells accumulated CDT1 as well as Spd1 in non-damaged 
cells (Figure 3.5), revealing a function of Ddb1 in controlling normal cell growth.    
    Related to this issue is the role of Skp2 in CDT1 degradation.  Accumulating evidence 
has suggested that another E3 ligase, possibly SCFSkp2, is involved in causing CDT1 
ubiquitination and degradation in mammalian cells (Li et al., 2003; Liu et al., 2004; 
Sugimoto et al., 2004).  Consistent with the presence of multiple E3 for CDT1 degradation, 
knocking down Ddb1, while accumulating abundant CDT1 following DNA damage, was not 
sufficient to accumulate CDT1 during normal cell growth (Higa et al., 2003; Hu et al., 2004).  
I have thus far obtained no evidence in fission yeast that would suggest the involvement of 
another E3 ligase in promoting CDT1 ubiquitination.  Deletion of Ddb1 accumulated CDT1 
to a very high level (Figure 3.5C), arguing that if there exists another E3 ligase in fission 
yeast that controls CDT1 ubiquitination, its activity must be very minor in comparison with 
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that of Ddb1.  Recently, Kim Y. et al reported that SCF Skp2 is not required for CDT1 
degradation in the normal cell cycle in C. elegans (Kim and Kipreos, 2006).  I suggest that 
the CUL4-DDB1 ligase evolved early to ubiquitinate CDT1 both during normal cell growth 
as well as in response to DNA damage.  Later in evolution, a separate E3 ligase evolved to 
share the function of CDT1 ubiquitination during normal cell growth, but DNA 
damage-induced CDT1 degradation continues to be carried out by the CUL4-DDB1 ligase. 
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Chapter IV 
 
CUL4-DDB1-FBW5-ROC1 TARGET TSC2 FOR DEGRADATION 
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Summary 
   Tuberous sclerosis (TSC) is an autosomal dominant disease characterized by hamartoma 
formation in various organs and is caused by mutations targeting either the TSC1 or TSC2 
genes.  TSC1 and TSC2 proteins form a functionally interdependent dimeric complex. 
Phosphorylation of either TSC subunit by different kinases regulates the function of TSC 
and represents a major mechanism to integrate various signals into a centralized cell growth 
pathway.  The majority of disease-associated mutations targeting either TSC1 or TSC2 
results in a substantial decrease in protein level, suggesting that protein turnover also plays a 
critical role in TSC regulation.  Here I report that TSC2 protein binds to FBW5, a 
DDB1-binding WD40 (DWD) protein, and is recruited by FBW5 to the DDB1-CUL4-ROC1 
E3 ubiquitin ligase.  Overexpression of FBW5 or CUL4A promotes TSC2 protein 
degradation, and silencing FBW5, DDB1 or CUL45A/B conversely stabilizes TSC2.  
Mutations targeting either Ddb1 or Cul4 in Drosophila result in TSC2 protein accumulation 
and cause growth defects that can be partially rescued by TSC2 reduction.  These results 
indicate that FBW5-DDB1-CUL4-ROC1 is an E3 ubiquitin ligase regulating TSC2 protein 
stability. 
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Background 
    mTOR plays a central role in controlling cell growth, proliferation and metabolism, and 
regulates numerous cellular processes, including translation, transcription, mRNA turnover, 
protein stability, actin cytoskeletal organization and autophagy (Inoki et al., 2005; Jacinto 
and Hall, 2003).  mTOR belongs to the phosphoinositide kinase-related kinase family, but it 
phosphorylate proteins instead of phosphoinositides (Harris and Lawrence, 2003).  
Ribosomal S6 kinase (S6K) and eukaryotic initiation factor 4E binding protein 1 (4EBP1), 
two essential regulators of protein translation, are the best-characterized substrates of mTOR 
(Harris and Lawrence, 2003).  S6K is the major kinase for the ribosomal protein S6, 
phosphorylation of which selectively increases the translation of mRNAs containing a tract 
of pyrimidines motif.  These mRNAs usually translate ribosomal proteins and other 
translation regulators, through which S6K enhances overall protein synthesis of the cell 
(Avruch et al., 2001; Meyuhas, 2000).  4EBP1, another target of mTOR, plays a role as a 
translation inhibitor by binding eukaryotic initiation factor 4E (eIF4E), which recognizes 5’ 
end cap of eukaryotic mRNAs (Gingras et al., 1999).   Phosphorylation of 4EBP1 by 
mTOR dissociates the interaction between eIF4E and 4EBP1, thereby relieving the 
inhibition of 4EBP1 on eIF4E (Gingras et al., 1999).  eIF4E increases the translation of a 
subset of growth stimulating factors, including Cylin D1, c-Myc and vascular endothelial 
growth factor (VEGF) (Mamane et al., 2004).  mTOR links the cell growth to multiple 
extracellular and intracellular signals, including growth factors, nutrients and energy (Harris 
and Lawrence, 2003; Inoki et al., 2003b; Jacinto and Hall, 2003).  All these signals act on 
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mTOR through the tuberous sclerosis complex (TSC) gene product TSC1 and TSC2.  
Tuberous sclerosis is an autosomal dominant disease that causes benign tumors (hamartomas) 
in a variety of organs with an incidence estimated to be 1 in 6000 live births.  TSC1 (also 
known as hamartin) and TSC2 (also known as tuberin) are two genes whose mutations are 
believed to cause this disease (Young and Povey, 1998).  TSC2 gene encodes a 200 kDa 
protein containing a coiled-coil domain and a GAP (GTPase activating protein) domain, 
which inhibits the small G protein Rheb, an activator of mTOR (Inoki et al., 2003a).   
    Ubiquitin-dependent proteolysis pathway has been reported to regulate a massive array of 
cellular functions.  Recently, two groups reported that PTEN, a regulator of the cell growth 
pathway, is ubiquitinated by a HECT domain ubiquitin ligase NEDD4-1 (Trotman et al., 2007; 
Wang et al., 2007).  TSC2 is a short-lived protein and it is readily ubiquitinated 
(Chong-Kopera et al., 2006).  Many disease-associated mutations in TSC1 and TSC2 result in 
a substantial decrease in the level of hamartin and tuberin, respectively (Inoki et al., 2002; 
Nellist et al., 2005), suggesting that protein turnover plays a critical role in TSC regulation. 
Identification of the ubiquitin ligase for TSC2 would shed light on the understanding of the 
regulation of TSC and cell growth pathways.  In Chapter II, I described that CUL4-DDB1 
utilize DWD proteins as receptors to target various substrates.  In the effort of identifying 
ubiquitin ligase of TSC2, my colleague Stuart Shumway and I discovered that Fbw5, a DWD 
protein, binds to TSC2 very tightly.  Following this discovery, I discovered that 
CUL4-DDB1-Fbw5-ROC1 complex targets TSC2 for ubiquitination.  
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Experimental procedures 
Plasmids, cell culture and cell transfection 
Plasmids expressing, and antibodies recognizing, human CUL4A, CUL4B, DDB1, 
ROC1 and CAND1, and procedures for immunoprecipitation and immunoblotting were as 
described in Chapter II.  Plasmids expressing GFP, SKP1, SKP2, CUL1, CUL2, CUL3 and 
CUL5 were described previously (Michel and Xiong, 1998).  Plasmids expressing CDT2 
and myc3-ubiquitin were obtained from collaborators Hui Zhang (Yale University, CT) and 
Anton Jetten (NIEHS, NC), respectively.  Plasmids expressing Flag-Ubiquitin, TSC1, 
TSC2 and TSC2 mutants were obtained from Kunliang Guan (University of Michigan at 
Ann Arbor, MI).  Plasmids expressing Fbw5 and Fbl6 were cloned from a HeLa cDNA 
library. Mutations were introduced by site-directed mutagenesis using the Quick-Change Kit 
(Stratagene, La Jolla, CA) and verified by DNA sequencing.  All human cells were cultured 
in DMEM containing 10% FBS in a 37 °C incubator with 5% CO2.  Cell transfections were 
performed using a calcium-phosphate buffer. 
 
Antibodies, proteins and immunological procedures  
    Antibodies to haemagglutinin (HA) (12CA5; Boehringer-Mannheim, Mannheim, 
Germany), to Myc (9E10; NeoMarker, Fremont, CA), to T7 (Novagen, Madison, WI) and to 
FLAG (M2; Sigma, St Louis, MO) were purchased.   Rabbit polyclonal antibody to ROC1 
has been described (Ohta et al., 1999) and rabbit polyclonal antibodies to CUL4A 
(N-MADEAPRKGSFSALVGRTNG-C), CDT1 (N-ADLAHITARLAHQTRAEEGL-C) and 
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DDB1 (N-REKEFNKGPWKQENVE-H) were raised against a synthetic peptide derived 
from the respective human proteins. Antibodies to TSC1 and TSC2 were described 
previously (Shumway et al., 2003; Zacharek et al., 2005).   Procedures for protein 
purification, immunoprecipitation and immunoblotting have been described (Furukawa et al., 
2003; Ohta et al., 1999).   
 
RNA interference 
     All siRNA oligonucleotides were synthesised with 3' dTdT overhangs by Dharmacon 
(Lafayette, CO) in a purified and annealed duplex form. The sequences targeting each 
human gene were as follows: Ddb1, 5'-CCUGUUGAUUGCCAAAAAC-3'; Ddb2, 
5'-GAGCGAGAUCCGAGUUUAC-3'; CUL4A, 5'-GAACUUCCGAGACAGACCU-3'; 
Cul4B, 5'-AAGCCUAAAUUACCAGAAA-3'; Cand1, 
5'-AATGATTTGATGACGGAACTG-3'; Fbw5, 
5’-CCAAGGAGGGCUUGCGGCACUUUCU -3’. OPTI-MEM medium (500 μl) was 
mixed with Lipofectamine 2000 reagent (10 μl) for 5 min and then incubated with 10 μl (20 
mM) of siRNA for 20 min at room temperature.  DMEM−10%-FBS medium (1.5 ml) was 
added to the mixture, and the entire 2.5 ml was added to HeLa cells cultured on a 60-mm 
plate at 30−40% confluency. The cells were transfected once with CUL4A+CUL4B, Ddb1 
and Fbw5 siRNA and analysed 48−72 h after transfection, and transfected three times with 
Cand1 siRNA every 24 h and analysed 24 h after the last transfection. 
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In vivo ubiquitin ligation assays. 
    The U2OS cells transfected with plasmids expressing HA3-TSC2 and Flag-Ubiquitin 
were further transfected with siRNAs targeting Fbw5, DDB1 or CUL4A+CUL4B, or 
scrambled siRNA.  The cells were lysed with SDS lysis buffer (50 mM Tris-HCl at pH 8.0, 
100 mM NaCl, 2% Triton X-100 and 1% SDS) and then the lysates were diluted with 10 
times of NP-40 buffer (50 mM Tris-HCl at pH 7.5, 150 mM NaCl, 0.5% NaCl and 50 mM 
NaF).  The diluted lysates were applied to immunoprecipitation with anti-HA antibody and 
immunoblotting with anti-Flag antibody.   
 
In vitro ubiquitin ligation assays. 
    The procedures for ubiquitin labeling were as described (Furukawa et al., 2003; Hu et 
al., 2004; Liu et al., 2002).  Briefly, to purify substrate, GST-TSC2 was ectopically 
expressed in 293T cells, extracted in RIPA lysis buffer (50 mM Tris-HCl at pH 8.0, 150 mM 
NaCl, 1% NP-40, 0.5% DOC and 0.1% SDS), and pulled down with Glutathione 
SepharoseTM 4B beads (Amersham Biosciences, Uppsala, Sweden) followed by 10 mM 
Glutathione elution.  To purify CUL4A, CUL1, FBL6 and FBW5 ligases, Myc3-CUL4A, 
Myc3-CUL1, Myc3-FBL6 and Myc3-FBW5 immunocomplexes were immunoprecipitated 
using anti-Myc antibody from transfected 293T cells, immobilized on protein A−agarose 
beads and washed three times with an NP-40 buffer (50 mM Tris-HCl at pH 7.5, 150 mM 
NaCl, 0.5% NaCl and 50 mM NaF) and twice with a ligase assay buffer (25 mM Tris-HCl at 
pH 7.5, 50 mM sodium chloride, 1 mM EDTA, 0.01% NP-40 and 10% glycerol).  
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Immobilized immunocomplexes were eluted by incubating with a molar excess of Myc 
peptide.  For the in vitro TSC2 ubiquitination, the different combination of CUL4A, CUL1, 
Fbw5 and Fbl6 immunocomplexes were mixed with GST-TSC2 substrate and the mixtures 
were added to an ubiquitin ligation reaction (final volume 30 μl) containing the following: 
50 mM Tris-HCl at pH 7.4, 5 mM MgCl2, 2 mM sodium fluoride, 10 nM okadaic acid, 2 
mM ATP, 0.6 mM dithiothreitol, 12 μg bovine ubiquitin, 1 μg ubiquitin (Sigma), 60 ng E1 
and 300 ng E2 (hUbc5c).  Reactions were incubated at 30°C for 60 min, terminated by 
boiling for 5 min in an SDS sample buffer containing 0.1 M dithiothreitol and resolved on an 
SDS−PAGE gel before immunoblotting with the anti-GST antibody to examine ubiquitin 
ladder formation. 
 
Drosophila mutants 
    Cul411L, Cul46AP, and Ddb1PL12c alleles were generated by imprecise excision of the P 
element in Cul4EP2518 and Ddb1EY01408 chromosomes, respectively, and will be described in 
detail elsewhere. The Cul4EP2518, Ddb1pic2, Ddb1S026316, and Ddb1EY01408 alleles were obtained 
from the Bloomington Stock Center.  gig192 was a kind gift of DJ Pan . 
 
Quantification of mean eclosion day and percentage of eclosed flies. 
    DDB1PL12c/ TM3 Sb, Ser P[act-GFP] females were crossed to either DDB1pic2/TM3 Sb, 
Ser P[act-GFP] or DDB1pic2 gigas/TM3 x DDB1pl12c/TM3 males, and Ddb1 mutant and 
heterozygous sibling progeny were counted.   For mean eclosion day calculations, the first 
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day any fly from the culture eclosed established day 1, and the genotype of all flies were 
scored each day for 9 and 12 successive days at 25°C and 18°C, respectively.  The 
experiment was performed in triplicate.  A 95% Confidence Interval test was used to obtain 
the range of the true mean of the combined data at each temperature.  Two tailed t-test 
assuming unequal variances was used to compare eclosion day data between different 
genotypes.   The percentage of eclosed flies was calculated using the combined data at each 
temperature and different genotypes were compared using Fisher’s exact test. 
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Results 
FBW5 binds to TSC1/2 and CUL4-DDB1  
To identify the TSC2 ubiquitin ligase, a yeast two-hybrid screen was performed using 
TSC2 as bait by Stuart Shumway, a former Post-doc in the lab, and several potential TSC2 
binding proteins were identified. Coupled immunoprecipitation and immunoblotting 
(IP-Western) analyses were then carried out to confirm these bindings in cells ectopically 
expressing TSC2 and individual prey proteins.  Two F-box proteins, FBL6 and FBW5, 
were found to bind with TSC2 (Figure 4.1A and data not shown).  Three additional control 
F-box proteins, SKP2, β-TrCP and FBX5, did not bind with TSC2 in the same assay (data 
not shown), indicating specificity of the FBL6-TSC2 and FBW5-TSC2 interaction and also 
suggesting that F-box motif is not sufficient for binding to TSC2.  Consistent with 
TSC1-TSC2 dimerization, FBW5 also associates with TSC1 (Figure 4.1A). The genetic 
study in Drosophila (see below) conducted by our collaborator Robert Duronio led me to 
focus on determining the function and mechanism of the FBW5-TSC interaction. The 
functional significance of FBL6-TSC interaction remains to be determined.  
 
   Human FBW5 is a 60 kDa (566 residues) protein containing two recognizable 
domains; an N-terminal located F box motif and a WD40 repeat occupying most of the rest 
of the sequence.   The F box motif functions to bridge a substrate protein to the 
CUL1-ROC1 E3 ligase via the SKP1 adaptor (Bai et al., 1996; Feldman et al., 1997; 
Skowyra et al., 1997).  Recently, we and others found that DDB1 binds to a subset of  
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Figure 4.1 CUL4/DDB1, TSC1/2 and Fbw5 associate with each other 
(A and B) 293T cells were transfected with plasmids expressing indicated proteins and 
protein-protein association was examined by coupled IP-Western analysis. (C) Endogenous 
TSC2-CUL4A association was determined by IP-Western analysis. 
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WD40 proteins, referred to as DWD proteins (also known as DCAF for DDB1- and  
CUL4 and DDB1-associated WD40 repeat proteins), and bridges them to CUL4-ROC1 to 
CUL4-associated factors or CDW to constitute a potentially large and distinct family of 
DWD-DDB1-CUL4-ROC1 E3 ubiquitin ligases (Angers et al., 2006; He et al., 2006; Higa et 
al., 2006b; Jin et al., 2006).  FBW5 contains two recognizable DWD box between residues 
436 to 451 and 484 to 499 (He et al., 2006), which led me to determine whether it can bind 
to and target TSC2 for ubiquitination by the DDB1-CUL4-ROC1 ligase.  
 
    I first examined the association between ectopically expressed TSC2 and 
DDB1-CUL4A complex in 293T cells.  TSC2, as well as its partner TSC1, was readily 
detected in both DDB1 and CUL4A immunocomplexes (Figure 4.1B).  Both TSC1 and 
TSC2 proteins were also readily detected in CUL4A immunocomplexes from un-transfected 
293T or U2OS cells (Figure 4.1C), demonstrating association between endogenous 
TSC1-TSC2 and DDB1-CUL4A.  The amount of TSC2 protein detected in CUL4A 
complexes is similar to or slightly greater than that detected by direct Western blotting using 
one tenth of the cell extract, suggesting that at least 10% of the total TSC2 is associated with 
DDB1-CUL4A in both 293T cells and U2OS cells.  I therefore conclude that the 
DDB1-CUL4 ligase plays a direct and important role in regulating the TSC complex in vivo.      
 
    To determine which domain, the F-box or the WD40 repeats, is required for FBW5 to 
bridge TSC1-TSC2 to DDB1-CUL4A, Stuart generated a mutant FBW5, FBW5ΔF, with a  
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Figure 4.2 F box is not required for bridging FBW5 to associate with DDB1-CUL4A.  
293T cells transfected with plasmid expressing myc-tagged wild-type or mutant FBW5 deleting the 
F-box (FBW5ΔF), followed by P-Western analysis to examine protein complex formation. 
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deletion of the F box motif.  FBW5ΔF mutant cannot bind to SKP1, but retains the ability to  
bridge TSC1 and TSC2 with DDB1-CUL4A (Figure 4.2 A and B), suggesting that the WD40 
repeats in FBW5 mediate TSC2 binding to DDB1. 
 
FBW5-DDB1-CUL4 ubiquitinate and degrade TSC2 in mammalian cells 
To determine whether FBW5-DDB1-CUL4 is an E3 ubiquitin ligase for TSC2 and 
promotes TSC2 degradation, I co-expressed TSC2 with a series of individual components of 
different E3 ubiquitin ligases.  Overexpression of FBW5 substantially reduced the steady 
state level of ectopically expressed TSC2 protein, while overexpression of another DWD 
protein, CDT2, or two F-box proteins, SKP2 and FBL6, did not exhibit any detectable effect 
on the level of TSC2 (Figure 4.3A).  In the same assay, overexpression of CUL4A also 
reduced the level of TSC2 protein.  Overexpression of ROC1 or DDB1 did not show any 
effect on TSC2 levels, suggesting that a sufficient amount of both proteins is present in the 
cells to support the ligase activity toward TSC2.  Overexpression of CUL1 also noticeably 
reduced the level of TSC2, albeit to a lesser extent than CUL4A overexpression, raising the 
possibility that TSC2 may be regulated by an additional, CUL1-mediated E3.  Consistent 
with the notion that FBW5ΔF is sufficient to bridge TSC2 to DDB1-CUL4A, overexpression 
of FBW5ΔF reduced TSC2 levels with a potency similarity to that of wild-type (Figure 4.3B).  
Degradation of TSC2 by FBW5 or FBW5ΔF was inhibited by the proteasome inhibitor 
MG132 (Figure 4.3B), indicating that FBW5-promoted TSC2 degradation is 
proteasome-dependent.  
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Figure 4.3 Overexpression of FBW5 decreases TSC2.  
(A) HA-tagged TSC2 was co-transfected with plasmids expressing various indicated proteins into 
293T cells. The steady state level of TSC2 protein was determined by direct immunoblotting.  (B) 
FBW5 promotes TSC2 degradation in a proteasome-dependent mechanism. 293T cells were 
co-transfected with plasmids expressing indicated proteins and were either untreated or treated with 
proteasome inhibitor MG132. The steady state level of TSC2 protein was determined by direct 
immunoblotting.   
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Figure 4.4 A C-terminal domain of TSC2 is both required and sufficient for FBW5-promoted 
degradation.   
 
Various TSC2 deletion mutants were co-transfected with FBW5 and the steady state level of TSC2 
protein was determined by direct immunoblotting. 
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    A series of deletion mutants of TSC2 were generated to map the region in TSC2 
required for its degradation by FBW5-DDB1-CUL4A.  All mutants containing amino acids 
from 1321 to 1765 were effectively degraded by the co-expression of FBW5, while all 
mutants missing this fragment were resistant to FBW5-promoted degradation (Figure 4.4C).  
These results suggest that fragment 1321-1765 of TSC2, which contains the Rap-GAP 
domain and is highly conserved during evolution, is necessary and sufficient to mediate 
TSC2 degradation by the FBW5-DDB1-CUL4 ligase.  
 
    To further demonstrate the function of FBW5, DDB1 and CUL4A/B in targeting TSC2 
protein degradation, I blocked protein newly synthesis with cycloheximide treatment and 
determined the half-life of TSC2 protein.  TSC2 is a short-lived protein with a half-life 
around 3 hours in control U2OS cells transfected with scrambled siRNA oligo (Figure 4.5A).  
Silencing either DDB1 or the combination of CUL4A and CUL4B increased the half-life of 
TSC2 to over 8 hours (the duration of the experiment), and silencing FBW5 increased the 
half-life of TSC2 protein to around 6 hours (Figure 4.5A).  These results suggest that 
FBW5-DDB1-CUL4 is an active E3 ubiquitin ligase which continuously ubiquitinates TSC2 
and promotes its degradation.  
 
    I next determined whether the FBW5-DDB1-CUL4-ROC1 ligase ubiquitinates TSC2.  
U2OS cells were co-transfected with plasmids expressing HA-tagged TSC2 and 
FLAG-tagged ubiquitin, and twelve hours later the cells were transfected with siRNA oligo 
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silencing DDB1, FBW5 or a combination of CUL4A/B.  TSC2 in vivo ubiquitination in 
these cells was analyzed by measuring the amount of HA-TSC2-FLAG-ubiquitin conjugates 
by IP/western.TSC2 protein is actively ubiquitinated and the level of TSC2 ubiquitination 
was substantially reduced by knocking down individually FBW5, DDB1 or CUL4A, with 
FBW5 knock down exhibiting the most pronounced effect (Figure 4.6A).  
 
    To demonstrate that the FBW5-DDB1-CUL4-ROC1 ligase directly promotes TSC2 
ubiquitination in vitro, I immunoprecipitated CUL4A complexes from transfected 293T cells 
and used it as a source of E3 ligase.  Incubation of purified GST-TSC2 substrate with 
CUL4A and FBW5 immunocomplexes resulted in robust TSC2 polyubiquitination in the 
presence of E1, E2-UBC5, ubiquitin and ATP (lane 1, Figure 4.7A).  Omitting either 
CUL4A (lane 3) or FBW5 (lane 5) or substitution of FBW5 with FBL6 (lane 2) abolished 
GST-TSC2 polyubiquitination.  To further confirm GST-TSC2 ubiquitination by the 
FBW5-DDB1-CUL4A-ROC1 ligase, we performed dropped out experiments (Figure 4.7B).  
Omitting individually E1 (lane 3), E2-UBC5 (lane 4), ATP (lane 5) and ubiquitin (lane 6) 
each eliminated GST-TSC2 polyubiquitination.  Consistent with the finding that the F-box 
motif is not required for mediating TSC2 ubiquitination by DDB1-CUL4A, FBW5ΔF was 
fully capable of substituting for wild-type FBW5 in promoting TSC2 ubiquitination (lane 2).  
Together, these results demonstrate that FBW5 recruits TSC2 to the DDB1-CUL4A-ROC1 
ligase for polyubiquitination in vitro.   
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Figure 4.5 Ablation of CUL4, DDB1 or Fbw5 stabilizes TSC2.  
(A) Silencing either DDB1, FBW5 or combination of CUL4A and CUL4B in mammalian cells 
increases the half-life of TSC2 protein. U2OS cells transfected with siRNA targeting indicated gene 
were treated with cycloheximide for different times. The steady state level of endogenous TSC2 as 
well as TSC1 was determined by direct immunoblotting.  (B) Accumulation of dTsc2/Gigas protein 
in dCul4 or dDdb1 mutant. Total protein extracts were prepared from larvae of wild type, two dCul4 
mutants and one dDdb1 mutant, and the steady state levels of dTsc2/Gigas protein were determined 
by direct immunoblotting.   
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Figure 4.6 In vivo ubiquitination of TSC2 by FBW5-DDB1-CUL4 ligase.  
CUL4A, DDB1 and FBW5 are required for TSC2 ubiquitination in vivo. U2OS cells were 
co-transfected with plasmids expressing HA-TSC2 and FLAG-Ubiquitin and siRNA targeting 
CUL4A+CUL4B, DDB1 or FBW5. Cells were lysed 24 hours after transfection and TSC2 
ubiquitination was analyzed by immunoprecipitating HA-TSC2 and blotted with an antibody 
recognizing FLAG. 
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Figure 4.7 In vitro ubiquitination of TSC2 by FBW5-DDB1-CUL4 ligase. 
 
(A) In vitro ubiquitination of TSC2 by FBW5 and CUL4A. 293T cells were co-transfected with 
plasmids expressing indicated myc-tagged proteins. Individual protein complex was eluted by 
incubating with molar excess myc antigen peptide and mixed as indicated with substrate GST-TSC2 
in the presence of E1, E2, ubiquitin and ATP. Reaction mixtures were incubated for 30 minutes, 
terminated by boiling directly in SDS-sample buffer, resolved by SDS-PAGE and immunoblotted 
with indicated antibodies. (B) Drop-out assay was carried out as described in (A) to determine the 
specificity of in vitro TSC2 ubiquitination. 
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CUL4-DDB1 ubiquitinate and degrade TSC2 in Drosophila 
To seek further in vivo evidence for FBW5-DDB1-CUL4-mediated TSC2 
degradation, my colleagues Bob Duronio, Sima Zacharek and Kate Lee turned to Drosophila 
melanogaster in which both the TSC-mediated cell growth control pathway and the 
DDB1-CUL4 E3 ligase are conserved.  Drosophila also contains a gene, CG9144, 
encoding an F-box and WD40 protein that exhibits 40% identity and 58% similarity to 
human FBW5, and thus represents an FBW5 homologue.  Sima generated and 
characterized a series of lethal mutations in the single Cul4 and Ddb1 genes (Zacharek et al. 
in preparation).  Cul46AP and Cul411L were generated by P-element-mediated excision 
mutagenesis, and encode predicted proteins containing C-terminal deletions of 82 and 65 
amino acids, respectively.  Cul411L produces no protein and is therefore null while Cul46AP 
produces a stable truncated protein (Figure 4.5B).  Ddb1S026316 and Ddb1EY01408 are 
P-element insertion null alleles that produce no detectable protein (Figure 4.5B).  Both 
Cul4 and Ddb1 null mutations cause growth arrest in the first (Cul4) or second (Ddb1) instar 
larvae, with the larvae capable of surviving for over 10 days on rich medium without 
growing (Figure 4.8A).  Immunoblot analysis of whole larval extracts revealed that TSC2 
protein dramatically accumulates in both Cul4 and Ddb1 mutants (Figure 4.5B).  The 
Cul411L/6AP genotype results in the accumulation of more TSC2 protein than the Cul46AP/6AP 
genotype, suggesting that the truncated Cul46AP protein retains some function, although the 
growth arrest phenotype between the two allele combinations is the same.  These results 
correlate TSC2 accumulation with the severity of Ddb1-Cul4 ligase impairment and provide 
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direct in vivo evidence that DDB1-CUL4 ligase controls TSC2 protein turnover.  
Sima also isolated and characterized viable Ddb1 hypomorphic alleles that cause 
growth defects.  It was determined by complementation analysis that a previously defined 
locus termed piccolo (pic) was allelic to Ddb1.  Semi-lethal piccolo mutants were 
originally characterized based on shared irregularities in bristle, wing, and tergite growth 
(Clark and Chovnick, 1985, 1986; Rushlow and Chovnick, 1984).  This type of growth 
defect is reminiscent of phenotypes observed in hypomorphic myc mutants and Minute 
mutants, which are heterozygous for null alleles of ribosomal protein genes (Figure 4.8B).  
pic2 is an X-ray induced hypomorphic allele of Ddb1 encoding a G21ÆD substitution that 
results in severely reduced Ddb1 protein levels (Zacharek et al. in prep.).  Sima generated 
another hypomorphic allele of Ddb1 (Ddb1pl12c) by excision of the Ddb1EY01408 P element 
located in the 5’UTR.  Ddb1pic2pl12c mutants develop into viable adults, but these flies show 
a significant developmental delay and eclose on average 2 and 4 days later than control 
siblings at 25°C and 18°C, respectively (Figure 4.8C).  In addition, these flies have cuticle 
defects including missing bristles and small bristles that resemble Min mutants (the piccolo 
phenotype; Figure 4.8B).  Reduction of TSC2 gene dose by half substantially suppressed 
the late eclosion phenotype and the semi-lethality of Ddb1pic2pl12c mutants (Figure 4.8C), but 
not the bristle defects.  These data suggest that TSC accumulation contributes to some of 
the growth defects caused by Ddb1 mutations, and also that Ddb1-Cul4 E3 ligases may have 
other targets.   
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Figure 4.8 Growth defects in Drosophila Cul4 and Ddb1 mutants. 
 
(A) Drosophila Cul4 mutant shows developmental arrest. The comparison of the first 
instar larvae of Cul4 heterozygosity Cul411L/+ and homozygosity Cul411L/11L.  
(B) Drosophila Ddb1 mutant shows small or missing bristles. The comparison of the 
second instar lavae of wild type, Min and Ddb1 mutant Ddb1pic.  
(C) Growth defects of Cul4 and Ddb1 mutants are rescued by heterozygosity of gig 
(TSC2). Total eclosed flies and mean eclosion time of Ddb1picsib, Ddb1pic/Ddb1pl12c, 
Ddb1pic2gig192sib and Ddb1pic2gig192/Ddb1pl12c were measured at 18 oC and 25 oC.    
 
These figures were made by Sima Zacharek and Kate Lee. 
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Discussion 
    In this study, I provided five lines of evidence supporting that 
CUL4-DDB1-FBW5-ROC1 ubiquitin ligase target tumor suppressor TSC2 for 
ubiquitination and degradation.  First of all, CUL4, DDB1 and FBW5 associate with TSC 
and TSC2.  Second, overexpression of FBW5 and CUL4A decrease the ectopically 
expressed TSC2 in cultured mammalian cells. Third, depletion of CUL4, DDB1 or FBW5 in 
cultured mammalian cells by RNAi increases the half-life of TSC2, and fly TSC2 is 
stabilized in Cul4 and Ddb1 mutants.  Fourth, CUL4, DDB1 and FBW5 are required for the 
ubiquitination of TSC2 in vivo and in vitro.  Finally, fly DDB1 hypomorphical alleles cause 
growth defects which can be rescued by reduction of TSC2 expression by half.  
   TSC2 is a central regulator of growth pathway and it is under precise regulation, mostly 
by phosphorylation.  Previous studies have shown that TSC2 activity can be inhibited by 
the kinase AKT and enhanced by as many as five other kinases: GSK3, AMPK, RSK, ERK 
and MAPKAPK2 upon various signals.  In this study, I showed that TSC2 can also be 
regulated by ubiquitin-proteasome pathway.  However, the signal(s) beyond this regulation 
remains mysterious.   TSC2 is a short-lived protein and it is turned over quickly, and the 
half-life of TSC2 can be increased by CUL4, DDB1 or Fbw5 RNAi (Figure 4.5A), so 
CUL4-DDB1-FBW5-ROC1 ubiquitin ligase might contribute to the constant degradation of 
TSC2 which does not need to be triggered by any signals.  However, the steady state level 
of TSC2 does not change in CUL4, DDB1 or FBW5 RNAi treated cultured cells (data not 
shown).  This could be due to a feed back loop involved by transcriptional and 
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post-translational regulation in cultured mammalian cells, which needs to be determined by 
further investigation.  This negative feed back loop may not exist or be partially disrupted 
in the early developmental stage in fly, because the steady-state TSC2 accumulates in Cul4 
and Ddb1 mutants.   
    The initial TSC2 yeast two-hybrid screen identified an F-box protein FBL6, whose 
binding with TSC2 was confirmed by IP-western (data not shown).  The solid binding of 
FBL6 and FBW5 with TSC2 suggests that potentially there are three ubiquitin ligases 
targeting TSC2 for ubiquitination: CUL4-DDB1-FBW5, CUL1-SKP1-FBL6 and 
CUL1-SKP1-FBW5.  Why TSC2 requires so many different ubiquitin ligases and under 
what circumstances these ligases play their roles needs to be further studied.   
    Both Cul4 and Ddb1 fly mutants show typical growth defects, such as developmental 
delay, late eclosion and small or missing bristles, which supports the notion that TSC2 is a 
substrate of CUL4-DDB1.  Consistently, the developmental delay and late eclosion 
phenotypes of Ddb1 hypomorphical alleles can be rescued by reduction of TSC2 level by 
half.  However, the small and missing bristle phenotype can not be rescued by TSC2 
heterozygosity, which suggests the tissue specificity of TSC2 function.  
    Human FBW5 gene localizes at chromosome 9q34.3 subtelomeric gene-rich region.    
Submicroscopic deletion del(9)(q34.3) is a rare constitutional microdeletion syndrome with 
around 40 cases reported (Faraone et al., 2006; Gao et al., 2007; Hampshire et al., 2006; 
Harada et al., 2004; Iwakoshi et al., 2004; Kleefstra et al., 2006a; Kleefstra et al., 2006b; 
Kleefstra et al., 2005; Medlej-Hashim et al., 2002; Saar et al., 1999; Sanger et al., 2005; 
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Stewart et al., 2004; Yatsenko et al., 2005).  Some clinical features of the del(9)(q34.3) 
syndrome have been related to the gene Euchromatin Histone Methyl Transferase1 
(Eu-HMTase1) (Kleefstra et al., 2006a; Kleefstra et al., 2005), but other features need to be 
linked to other specific genes.   Yatsenko et al. summarize the clinical features and 
corresponding genotypes of 15 del(9)(q34.3) patients (Figure 4.9).  FBW5 gene localizes 
between two genes TRAF2 and COBRA1, and according to Yatsenko et al., there are four 
clinical features could be linked to FBW5 gene: infections, brain anomaly, epilepsy or 
seizures and vascular and cardio anomalies.  Whether these features are caused by FBW5 
mutation or deletion needs to be further determined.   
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Figure 4.9 Clinical features linked to 9q34.3 region. (A) Physical map of the 9q34.3 
region (top) including known markers and their megabase position. The microsatellite 
markers are ordered approximately to scale according to their physical location in the contig. 
Horizontal lines show respective locations of the FISH probes (below). Filled black dots 
above clone 48C7 represent fosmid clones. (B) Schematic representation of the 9q34.3 
deletions in 15 patients determined by FISH and genotype analyses. Five individuals (KCL1, 
KCL2, KCL3, KCL4, KCL5) (Yatsenko et al., 2005)were characterised by FISH in the 
present study. Clinical and molecular data on 10 informative patients reported elsewhere 
include patients P2, P5–9, P12, (Stewart et al., 2004) and cases B, C, and E (Harada et al., 
2004). The left part of the figure shows the extent of deletion in each patient. Non-deleted 
chromosome regions are represented by filled horizontal bars. The hatched bars identify 
either uninformative or inconclusive areas. The deleted regions in each patient are indicated 
by a double dashed line. On the right side of the figure the clinical features in the patients are 
given according to the initial letters of anomaly (Trigonocephaly, Genitourinary anomaly, 
Brain anomaly, Epilepsy or seizures, congenital Vascular and cardiac anomalies, Laxity of 
joints, Infection susceptibility, Craniofacial dysmorphism, Hypotonia, Obesity, 
Microcephaly, Speech impairment). +: feature present; –: feature absent; blank: feature not 
reported or not verified. (C) Phenotypic differences correlated with 9q34.3 deletion size. 
Open rectangles represent the proposed position of critical regions for individual clinical 
findings. The critical intervals defined are based on the subject with the particular 
phenotypic feature and the smallest deletion. Transcribed genes in the critical interval are 
represented by arrows; EMHT1 is represented by a broken arrow to indicate alternative 
splicing.  From Yatsenko, S.A., Cheung, S.W., Scott, D.A., et al. Journal of medical 
genetics 42, 328-335, 2005. 
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Chapter V 
CONCLUSION AND PERSPECTIVES 
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    When I began to study ubiquitin-proteasome pathway in Dr. Xiong lab around four 
years ago, there was little known about CUL4's function: neither the substrates nor the 
substrate-targeting mechanism.  We knew, at that point, CUL4 is a member of cullin family 
proteins, there are two CUL4s in human: CUL4A and CUL4B, and CUL4A gene is 
amplified in human liver and breast cancers.  Through the hard work of our lab and many 
other labs, the function of CUL4 is becoming clearer.  The data presented here and the 
studies published by other labs enriched our knowledge of the substrates and the 
substrate-targeting mechanism of CUL4, in the meantime, they have also spurred a myriad 
of questions perplexing the field.  The ideas described below are the results of the ongoing 
discussions in our lab and worth to be pursued in the future. 
 
How many substrates can CUL4 target? 
    As already described, DDB1 is the most abundant binding protein in CUL4A complex 
(Figure 2.1), which associates with CUL4A nearly stoichiometrically.  Up to now, there are 
nine substrates of CUL4 have been reported: CDT1, H2A, H3, H4, CSB,  XPC, HOXA9, 
c-Jun and Spd1, among which CDT1, H2A, H3, H4, CSB, XPC, c-Jun and Spd1 are 
recruited to CUL4 through the adaptor protein DDB1.  The targeting mechanism through 
which HOXA9 is recruited to CUL4 is not clear.  My colleagues and I have described  
that CUL4-DDB1 could target multiple substrates through one of DWD (DDB1 binding 
WD40) proteins.  Consistent with this notion, CDT1 and Spd1 have been reported to be 
recruited to CUL4-DDB1 through a DWD protein CDT2.  Similarly, recruitment of 
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substrates H2A, H3, H4 and XPC have been linked to DWD protein DDB2, CSB has also 
been linked to CSA, and H3 has been linked to WDR5.   It has been established that the 
SKP1 adaptor bridges an F-box protein to CUL1-dependent ligases (Bai et al., 1996; 
Feldman et al., 1997; Skowyra et al., 1997; Zheng et al., 2002a), a heterodimeric elongins B 
and C complex brings VHL (von Hippel-Lindau) box proteins and SOCS (suppressor of 
cytokine signaling) box proteins to CUL2-dependent and CUL5-dependent ligases, 
respectively (Kamura et al., 2001; Kamura et al., 2004; Kamura et al., 1998; Stebbins et al., 
1999; Zhang et al., 1999), whereas CUL3 binds directly to the BTB domain 
(Broad-Complex C (BR-C), Tramtrack (Ttk) and Bric-a-brac) (Furukawa et al., 2003; Geyer 
et al., 2003; Pintard et al., 2003; Xu et al., 2003).  The presence of numerous substrate 
specificity factors — mammals express more than 60 F-box, 40 SOCS and 200 BTB 
proteins — suggests that individual cullins may assemble into multiple E3 ligase complexes.  
We and other labs have shown that there are more than 100 DWD proteins in human, which 
suggests that CUL4-DDB1 could target at least 100 different substrates.  An ongoing 
project in our lab is to test the interaction of CUL4-DDB1 and DWD proteins one by one 
and identify DWD protein associated proteins, through which the substrate pool of 
CUL4-DDB1 could be expanded.   
    WD40 proteins form a propeller-like structure, typically with seven blades, each 
composed of four anti-parallel -sheets.  There are >700 human WD40 repeat protein 
entries in the current PFAM database (http://www.sanger.ac.uk/Software/Pfam/index.shtml), 
corresponding to 320 unique genes after eliminating duplicates and truncated forms.  A 
   
                                                 103 
16-residue stretch that we refer to as the DWD box (DDB1-binding and WD40 repeat) 
(Figure 5.1) is defined by three features.  (1) The first 14 residues in the DWD box 
correspond to the second half of a WD40 repeat that is more conserved than other WD40 
repeats.  These 14 residues include three highly conserved residues, Asp7, Trp13, and 
Asp14; five hydrophobic residues (Ile, Leu, or Val) at positions 1, 2, 10, 12, and 15; and 
three small residues (Ala, Gly, Ser, or Thr) at position 3, 4, and 5.  (2) Arg16 following the 
WD dipeptide is a signature residue of the DWD box.  The crystal structure of the 
heterotrimeric G protein 1 subunit, a DWD protein , has been solved and shows that several 
conserved residues, including the Arg16, within the DWD box are located on the protein 
surface (Sondek et al., 1996), suggesting that these residues might participate in binding with 
other proteins.  (3) A DWD protein usually contains one and sometimes two DWD boxes, 
but rarely three.  According to the definition of the DWD box, Arg16 is the critical residue 
for the binding between DWD protein and DDB1, and we presented some data in the paper 
that mutation of Arg16 in CSA, PWP1 and APG16L disrupts or reduces the binding with 
DDB1.  However, further study in our lab showed that mutation of Arg16 in some other 
DWD proteins, such as FBW5, WSB1, RBBP4 and GRWD1, did not change the binding 
with DDB1, suggesting that Arg16 is not the residue required for the binding.  This 
discrepancy needs to be addressed by further study, especially crystal structural analysis.   
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Figure 5.1 Identification of a putative DDB1-binding motif in WD40 proteins, the DWD 
box. The DWD box is predicted to be present in >100 human WD40 repeat proteins. 
 
 
 
 
 
 
 
CSA (178) SHILQGHRQEILAVSWSPRYDYILATASADSRVKLWDVR 
DDB2 (234) LWNLRMHKKKVTHVALNPCCDWFLATASVDQTVKIWDLR 
CDT2 (207) GLAPSVDFQQSVTVVLFQDENTLVSAGAVDGIIKVWDLR 
WDR23 (348) VGALAGHQDGITFIDSKGDARYLISNS-KDQTIKLWDIR 
KIAA0800 (798) DVRSAQAIHKFDKFNMNISGVFHPNGLEVIINTEIWDLR 
GNB2 (176) TVGFAGHSGDVMSLSLAPDGRTFVSGAC-DASIKLWDVR 
KATNB1 (106) LRTLMGHKANICSLDFHPYGE-FVASGSQDTNIKLWDIR 
RBBP7 (258) SHLVDAHTAEVNCLSFNPYSEFILATGSADKTVALWDLR 
FBXW5  (462) AHRAYTPNDECFFIFLDVSRD-FVASGAEDRHGYIWD-R 
FBXW8 (250) GNIALSLSAHQLRVSAVQMDDWKIVSGGEEGLVSVWDYR 
NUP43 (209) ILSLTGDRVPLHCVDRHPNQQHVVATGGQDGMLSIWDVR 
APG16L  (387) RHTLTGHSGKVLSAKFLLDNARIVSGS-HDRTLKLWDLR 
RBBP4 (264) SHSVDAHTAEVNCLSFNPYSEFILATGSADKTVALWDLR  
GRWD1 (300) LTTATAHDGDVNVISWSRREPFLLSGG-DDGALKIWDLR 
WSB1 (163) LNLVDHTEVVRDLTFAPDGSLILVSAS-RDKTLRVWDLK 
WSB2 (189) QIQVLSGHLQWVYCCSISPDCSMLCSAAGEKSVFLWSMR 
PWP1 (293) ASLAVHTDKVQTLQFHPFEAQTLISGS-YDKSVALYDCR 
 
COP1 (463) PENEMTCNSKISCISWSSYHKNLLASSDYEGTVILWDGF 
CDC20 (350) TFTQHQGAVKAVAWCPWQSNVLATGGGTSDRHIRIWNVC 
LLSGGXDXTLXLWDLR
------E-S---YE-K
Color Code 
L Hydrophobic T Polar    D Acidic 
W Aromatic G Small    R Basic 
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Are CPSF160, SAP130 and Rik1 adaptors for CUL4? 
    If the primary sequence of DDB1 protein was aligned in NCBI database, no 
homologous sequence would be fished out.  Neuwald A. and Poleksic A. combined a 
multiple alignment procedure based on hidden Markov models (HMMs) that incorporates 
rather specific structural features with a PSI-BLAST search (Altschul et al., 1997) initialized 
with a profile corresponding to the HMM alignment and identified three structural 
homologies of DDB1: CPSF160 (Cleavage and polyadenylation specificity factor 160 kDa 
subunit) and SAP130 (Spliceosome-associated protein 130) in human and Rik1 in fission 
yeast, which were all predicted to share β-propeller domains with DDB1 (Neuwald and 
Poleksic, 2000) (Figure 5.2).   
    Could CPSF160, SAP130 and Rik1, like DDB1, be adaptors for CUL4?  To test this 
hypothesis, I determined the binding between ectopically expressed CPSF160/SAP130 and 
CUL4A/B using IP-Western assay which showed positive (data not shown).  If CPSF160 
and SAP160 are adaptors for CUL4, they might also use DWD proteins to target substrates.  
To test this possibility, Paula de Marval in our lab determined the binding between CPSF160 
and a few DWD proteins, and she found that CPSF160 binds to DDB2, CSA, FBW5 and 
FBW8 (data not shown), suggesting that like DDB1, CPSF160 and SAP130 could target 
various substrates through different DWD proteins.  As previously described in the chapter 
II, DDB1 is the major adaptor for CUL4, then if CPSF160 and SAP130 play a role as 
adaptors for CUL4, they must play a minor role or function under certain circumstances.   
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Figure 5.2 The propeller cluster structure of DDB1 family proteins.  
 
(A) Structural domain arrangement of DDB1 as determined from the DDB1 crystal. The four 
domains of DDB1 are colored differently with the conventionally named top faces of each 
propeller indicated. The a-d strands of BPA's blade 2 are individually labeled. (B) Schematic 
diagram of the secondary structure and domain arrangement of DDB1. The top surface loops 
of each propeller, which connect interblade d-a and b-c strands, are drawn in solid lines, 
whereas the bottom surface loops, which link intrablade a-b and c-d strands, are plotted in 
dash lines. (C) Domain architectures for UV-DDB-127 repeat proteins. Repeats are colored 
red proportional to their likelihood scores using lighter shades for less conserved repeats. 
Protein names are color coded according to families. The numbers of repeats are indicated in 
parentheses. (A) and (B) are from Li T. et al. Cell. 124:105-17, 2006; (C) is from Neuwald A. 
and Poleksic A. Nucleic Acids Research. 28: 3570-3580, 2000.  
C 
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Although DDB1, CPSF160 and SAP130 have been shown to bind DWD proteins ectopically, 
the endogenous bindings and the physiological relevance of these bindings need to be further 
determined.  The subsequent question is whether DDB1, CPSF160 and SAP130 bind the 
whole pool of the DWD proteins or only subset of it.  Addressing these questions could 
greatly enrich our knowledge on the function of CUL4.  
 
Important potential substrates of CUL4 
   Null mutation of DDB1 gene in mouse causes early embryonic lethality (Cang et al., 
2006; Cang et al., 2007).  Conditional inactivation of DDB1 in brain, lens and epidermis 
leads to genomic instability, aberrant cell cycle and elimination of proliferating progenitor 
cells.  Considering the myriad substrates of the CUL4-DDB1 ubiquitin ligases, the 
phenotypes of DDB1 null mice could be the result of malfunction of multiple cellular 
processes.  Consistent with previously published papers, several reported substrates of 
CUL4-DDB1, Cdt1, c-Jun and p27 are accumulated in DDB1 null mice.  p53 and p21, two 
proteins which are not supposed to be the substrates of CUL4-DDB1, are also up-regulated 
in DDB1 null epidermis.  DDB1-/- phenotype can be partially rescued by crossing with 
p53-/-.  p53 accumulation, however, might be an indirect effect of DDB1 inactivation, 
which could be caused by genomic instability and aberrant cell cycle.  Nevertheless, the 
study in our lab showed that p53 is readily detectable in CUL4A immunocomplex (data not 
shown).  p53 has been reported to be targeted for ubiquitination by COP1, a WD40 protein 
which associates with CUL4-DDB1-DET1 complex (Dornan et al., 2004).  A reasonable 
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hypothesis is that one of the CUL4-DDB1 ubiquitin ligases targets p53 for ubiquitination, 
probably through COP1 or one of DWD proteins.  COP1 is composed of a RING finger 
domain and a WD40 repeat, and its catalytic activity could be boosted by recruiting another 
RING finger protein, ROC1, through CUL4-DDB1-DET1 complex.  These hypotheses are 
worth to be tested in the future and would strengthen our understanding on CUL4 function, 
cell cycle regulation and apoptosis.  p21, on the other hand, is more likely to be an 
authentic substrate of CUL4-DDB1, because p21 is accumulated in both DDB1-/- and 
DDB1-/- p53-/- double null mice, suggesting that p21 up-regulation is not due to 
transcriptional enhancement.  One way to find out which DWD protein recruits p21 to 
CUL4-DDB1 is to test the bindings between p21 and DWD proteins one by one.  This 
method may look tedious, but could be very effective, and is definitely worth to try. 
 
Hijacking CUL4-DDB1 by viral proteins  
   So far, there are three viral proteins have been reported to hijack CUL4-DDB1: 
paramyxovirus V protein (Andrejeva et al., 2002; Li et al., 2006b; Lin et al., 1998; Precious 
et al., 2005; Ulane et al., 2005; Ulane et al., 2003), hepatitis B virus X protein (Bergametti et 
al., 2002; Bontron et al., 2002; Leupin et al., 2005; Leupin et al., 2003; Sitterlin et al., 2000) 
and HIV1 Vpr (Le Rouzic et al., 2007; Schrofelbauer et al., 2007).  The mechanism 
through which paramyxovirus V protein hijacks CUL4-DDB1 is rather clear: V protein plays 
a role as a substrate-targeting molecule to recruit STAT1/2/3 to CUL4-DDB1 and promote 
their ubiquitination, thereby suppresses the immune response of the host (Precious et al., 
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2005; Ulane et al., 2005; Ulane et al., 2003).  However, the functions of hepatitis B virus X 
protein and Vpr still remain elusive.  Chad McCall, a graduate student in our lab, identified 
a Vpr binding protein (VprBP) in CUL4A immunocomplex.  VprBP is a DWD protein and 
it has been shown to bind Vpr directly through direct yeast-two hybrid assay (Zhang et al., 
2001).  In a recently published paper, Schrofelbauer B. et al. identified a large amount of 
DDB1 from Vpr immunoprecipitation (Schrofelbauer et al., 2007).  The exact function of 
Vpr hijacking CUL4-DDB1 is still not clear.  Vpr has been shown to cause UNG2 
(uracil-DNA glycosylase) degradation (Schrofelbauer et al., 2005), G2-arrest and apoptosis 
(Jowett et al., 1995; Nishizawa et al., 2000; Shostak et al., 1999), all of which have been 
shown to be dependent on CUL4-DDB1 (Le Rouzic et al., 2007; Schrofelbauer et al., 2007).  
The role of VprBP in CUL4-DDB1-Vpr complex and the molecular basis for G2-arrest and 
apoptosis are being pursued in our lab currently.  
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